Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X1050.Time spend outdoors in summer,48657,-0.0629616575377484,0.0182479633047571,-0.0987276656150724,-0.0271956494604244,0.000560837642425405
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X1060.Time spent outdoors in winter,44984,-0.0431236720519408,0.0208650692601505,-0.0840192078018357,-0.00222813630204586,0.0387666540045161
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X1070.Time spent watching television (TV),50218,-0.0694027794067332,0.0186427587972564,-0.105942586649356,-0.0328629721641107,0.000197465154971489
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X1080.Time spent using computer,44969,-0.0461702798904294,0.0197177155100329,-0.0848170022900939,-0.00752355749076487,0.0192126838965046
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X1090.Time spent driving,42372,-0.0731436257417659,0.0213356595774612,-0.11496151851359,-0.0313257329699421,0.000608888418252403
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X1160.Sleep duration,51740,0.0148941523020474,0.016894521423894,-0.0182191096887849,0.0480074142928796,0.378002770762316
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,34019,-0.0249747769064778,0.0222366769591707,-0.0685586637464523,0.0186091099334967,0.261408600017505
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,34019,0.0155178039342376,0.0200220740640816,-0.0237254612313623,0.0547610690998376,0.438338258452376
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,34019,0.0595852770262561,0.0239263622890438,0.0126896069397303,0.106480947112782,0.0127781783098251
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,34019,0.0273964884516267,0.0245233755037052,-0.0206693275356356,0.0754623044388889,0.263954771602297
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,34019,0.0625046187790588,0.0247762426225441,0.0139431832388722,0.111066054319245,0.0116597216514789
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,34019,-0.00801649668927953,0.0474971818946314,-0.101110973202757,0.0850779798241981,0.865974544643557
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,34019,-0.0154822422572135,0.047246854710674,-0.108086077490135,0.0771215929757075,0.74315450883988
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,34019,0.00804197368219609,0.0363633323363554,-0.0632301576970604,0.0793141050614526,0.824975590039181
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,34019,0.0641129680735457,0.026084721997254,0.0129869129589279,0.115239023188164,0.0139938110484973
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,34019,0.00852126956947183,0.0180094833015801,-0.0267773177016251,0.0438198568405688,0.636113692111414
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#18.Location of pain during the past week_Upper back,34019,0.0174259165214873,0.0251358543904127,-0.0318403580837217,0.0666921911266963,0.488157386468089
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#19.Location of pain during the past week_Lower back,34019,0.0172913634167367,0.0153564479720713,-0.012807274608523,0.0473900014419963,0.260193681149549
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,34019,0.027749566949735,0.0191457458682255,-0.00977609495198698,0.0652752288514571,0.147262725881749
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,34019,-0.01021612944206,0.0273270699970097,-0.0637771866361991,0.043344927752079,0.708526806904014
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,34019,-0.0182715739126946,0.0260492439418379,-0.0693280920386969,0.0327849442133078,0.483055293514529
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,34019,0.0138547435462144,0.0365350518891826,-0.0577539581565834,0.0854634452490122,0.704534519225388
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,34019,-0.0525532604840793,0.033808172423273,-0.118817278433694,0.0137107574655358,0.120109156747265
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#7.Location of pain during the past week_Left hip,34019,0.0311412557857315,0.0204471219763435,-0.00893510328790173,0.0712176148593647,0.127788220811709
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#8.Location of pain during the past week_Right hip,34019,0.0485533951010522,0.0190394771967798,0.0112360197953638,0.0858707704067405,0.0107833134885352
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,34019,0.0295990204317097,0.0253656948286087,-0.0201177414323633,0.0793157822957827,0.243283165994725
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120040.Fatigue severity over the past week,34025,0.0785108918714631,0.0296242185562994,0.0204474235011163,0.13657436024181,0.00805701013419659
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120041.Waking unrefreshed severity over the past week,34022,0.0386901177019161,0.0295529937580235,-0.0192337500638099,0.0966139854676421,0.190505634039357
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120042.Cognitive symptoms severity over the past week,34022,0.0857033162708598,0.031631008883795,0.0237065388586215,0.147700093683098,0.00675105103832804
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120098.Mobility problems today,34029,0.088558724874064,0.0348137719956121,0.0203237317626643,0.156793717985464,0.0109814617694292
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120099.Self-care problems today,34029,0.0356567925339996,0.0549900724775399,-0.0721237495219785,0.143437334589978,0.516727363724735
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120100.Problems doing usual activities,34029,0.0630469000813653,0.0330334783494103,-0.00169871748347891,0.127792517646209,0.0563466988232046
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120101.Pain or discomfort today,34029,0.015413334858871,0.029721016740235,-0.0428398579519897,0.0736665276697316,0.604051328973003
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120102.Anxiety or depression today,34029,0.0109374941731686,0.0347742270658549,-0.0572199908759071,0.0790949792222442,0.753126337951294
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120103.Scale to indicate how health is today,33991,-0.0197591229002539,0.00660567505238585,-0.0327062460029302,-0.00681199979757763,0.00278562153629503
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,34004,0.0149414065413831,0.0358319257146275,-0.0552891678592867,0.085171980942053,0.676698119176656
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",33981,0.0258316107633676,0.036019199906089,-0.0447660210525669,0.096429242579302,0.473291565736707
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",34011,-0.011110865913146,0.0293402491705593,-0.0686177542874422,0.0463960224611502,0.70492631601791
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,34005,0.0245717195279436,0.0301910960933676,-0.0346028288150569,0.0837462678709441,0.415737969470516
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,34014,0.00692686768581963,0.0363594475057513,-0.064337649425453,0.0781913847970923,0.848912920698409
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120109.Feeling bad about self over the last two weeks,33985,0.00834414486062171,0.0379724345016142,-0.0660818267625422,0.0827701164837856,0.826076672341633
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120110.Trouble concentrating over the last two weeks,34009,0.0775214027206111,0.03925220447974,0.000587081940320811,0.154455723500901,0.0483018065557018
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,34000,0.0914109092983781,0.0573106130343659,-0.020917892248979,0.203739710845735,0.110743461083444
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,33963,-0.0294855872696451,0.0768181030825218,-0.180049069311388,0.121077894772098,0.701108259110181
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",31647,0.0544626553394147,0.0390777379244448,-0.0221297109924972,0.131055021671327,0.16345118010807
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X1269.Exposure to tobacco smoke at home,49419,-0.0318588359743388,0.0410614087289666,-0.112339197083113,0.0486215251344358,0.437825607778602
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,47580,-0.0356317589429421,0.0264993579886935,-0.0875705006007814,0.0163069827148972,0.178758824951295
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X1289.Cooked vegetable intake,51201,-0.0132498894812163,0.01749418424692,-0.0475384906051796,0.021038711642747,0.448823969151808
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X1299.Salad  or  raw vegetable intake,50703,-0.010982215543486,0.0189883501957803,-0.0481993819272153,0.0262349508402434,0.563022026956574
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X1309.Fresh fruit intake,51247,0.0519698169655858,0.0182323628264832,0.0162343858256787,0.0877052481054929,0.00436954194326989
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X1319.Dried fruit intake,49497,0.0684057981906078,0.0183218497026993,0.0324949727733172,0.104316623607898,0.000189207069004753
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X134.Number of self-reported cancers,52026,0.084203179059168,0.0305302520753022,0.0243638849915756,0.14404247312676,0.0058190159694806
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X135.Number of self-reported non-cancer illnesses,52026,0.0592178904659411,0.017474711771171,0.0249674553944459,0.0934683255374364,0.000703034809198418
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,"X136.Number of operations, self-reported",52026,-0.0519468715657378,0.0176656717269409,-0.0865715881505419,-0.0173221549809337,0.00327897355172688
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X137.Number of treatments or medications taken,52026,0.0755249019929073,0.0171571274274376,0.0418969322351296,0.109152871750685,1.07682640258384e-05
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X1438.Bread intake,51090,0.0170798053829541,0.00441488963179138,0.00842662170464294,0.0257329890612652,0.000109685444957565
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X1458.Cereal intake,50631,0.0865338714148604,0.0174144056666392,0.0524016363082476,0.120666106521473,6.76893732781283e-07
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X1488.Tea intake,51101,0.0184638379177856,0.00411947252305318,0.0103896717726013,0.0265380040629698,7.42239898982402e-06
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X1498.Coffee intake,49848,0.0415905971371105,0.0176135812262068,0.00706797793374513,0.076113216340476,0.0182194817861597
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X1528.Water intake,50298,-0.0157368578112788,0.0179695527519097,-0.0509571812050219,0.0194834655824643,0.381173430601406
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X1568.Average weekly red wine intake,41312,-0.0393537790024257,0.0215711712978543,-0.0816332747462202,0.0029257167413687,0.0681139765787666
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,41311,-0.128040309085477,0.0217797354678183,-0.1707285906024,-0.0853520275685528,4.20865653882434e-09
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X1588.Average weekly beer plus cider intake,41333,-0.0482895859594069,0.0273972387977574,-0.101988174003011,0.00540900208419766,0.0779909206430563
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X1598.Average weekly spirits intake,41263,-0.0959620311766074,0.0242944504166534,-0.143579153993248,-0.0483449083599667,7.84842316646573e-05
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X1608.Average weekly fortified wine intake,41342,0.119726700638863,0.0373576908400253,0.0465056265924135,0.192947774685313,0.00135372654699696
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X1737.Childhood sunburn occasions,45470,0.0743463569533674,0.0209456161946573,0.0332929492118392,0.115399764694896,0.000386813303725332
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X1807.Father's age at death,44577,0.0122549488169346,0.00475045690538223,0.00294405328238547,0.0215658443514838,0.00989446611953003
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X1845.Mother's age,35209,0.0202493149215278,0.010797661622862,-0.00091410185928174,0.0414127317023373,0.0607726715555654
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X1873.Number of full brothers,51514,-0.0021184467914445,0.0169619279855768,-0.0353638256431749,0.0311269320602859,0.900608220809563
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X1883.Number of full sisters,51520,0.00404437362136439,0.0170286653308559,-0.0293318104271131,0.0374205576698419,0.81226772831954
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X20015.Sitting height,51834,-0.0123140710089637,0.00544122975785815,-0.0229788813343657,-0.00164926068356177,0.0236370501077741
PLA2G10,Group 10 secretory phospholipase A2,Cognitive function,X20016.Fluid intelligence score,33298,0.0359262037619898,0.0277598183531459,-0.0184830402101761,0.0903354477341558,0.195637058716609
PLA2G10,Group 10 secretory phospholipase A2,Cognitive function,X20018.Prospective memory result,33638,0.0489500526841639,0.03670552379146,-0.0229927739470977,0.120892879315425,0.182371928136515
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),33178,0.00406096676685126,0.00762182477211682,-0.0108778097864977,0.0189997433202002,0.594180285397276
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),33159,0.00863375253535852,0.00759016984515167,-0.00624298036113876,0.0235104854318558,0.255364239800979
PLA2G10,Group 10 secretory phospholipase A2,Cognitive function,X20023.Mean time to correctly identify matches,51717,0.00898618464747419,0.00445916809062532,0.000246215189848558,0.0177261541050998,0.0438918690335883
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20107#1.Illnesses of father_Heart disease,48820,-0.0144118989484185,0.00912292477433333,-0.0322928315061119,0.00346903360927479,0.114178150836436
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,48389,-0.0107077096756994,0.0198220458064276,-0.0495589194562975,0.0281435001048986,0.589069685836468
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,48363,0.00123334216722847,0.026905793048139,-0.051502012207124,0.0539686965415809,0.963438734002308
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20107#12.Illnesses of father_Severe depression,48378,0.0364778024444355,0.0217456275325838,-0.00614362751942871,0.0790992324082997,0.0934621936043687
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,48382,0.0122911471063054,0.0163115925027096,-0.0196795741990055,0.0442618684116163,0.451143588154149
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20107#2.Illnesses of father_Stroke,48545,0.0109083001591313,0.0118595579642957,-0.0123364334508883,0.034153033769151,0.357691836056897
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20107#3.Illnesses of father_Lung cancer,48482,-0.0250000120986839,0.0149334122719558,-0.0542695001517173,0.00426947595434955,0.0941241378737624
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,48390,-0.00142013102381451,0.0189809985827176,-0.038622888245941,0.035782626198312,0.940359697864945
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,48538,-0.00429708905764552,0.013429396071248,-0.0306187053572917,0.0220245272420006,0.748989038714991
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20107#8.Illnesses of father_High blood pressure,48589,0.00258563376513759,0.0101485852508305,-0.0173055933264901,0.0224768608567653,0.798896928041508
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20107#9.Illnesses of father_Diabetes,48466,-0.0210260019523362,0.01422068990273,-0.048898554161687,0.00684655025701467,0.139273723538413
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20110#1.Illnesses of mother_Heart disease,50185,0.0266157642736211,0.0101710870864692,0.00668043358414147,0.0465510949631008,0.00888085848731512
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,50056,-0.0573251282110571,0.0148058419680271,-0.0863445784683903,-0.0283056779537239,0.00010830673691766
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,49987,0.0135390137560492,0.0316797105486114,-0.0485532189192292,0.0756312464313277,0.669112174276185
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20110#12.Illnesses of mother_Severe depression,50026,0.00869211521878918,0.0159619330307746,-0.022593273521529,0.0399775039591073,0.586065877490015
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20110#2.Illnesses of mother_Stroke,50119,0.0144024753827035,0.0116852550201856,-0.0085006244568602,0.0373055752222673,0.217760922891461
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,50009,-0.0751607207140787,0.0216281737777518,-0.117551941318472,-0.0327695001096851,0.000511451978965074
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,50006,-0.0212653580079918,0.0191192918585972,-0.0587391700508423,0.0162084540348587,0.266042810452323
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,50037,0.00579540658018602,0.0152857770939042,-0.0241647165238661,0.0357555296842382,0.704589136680531
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,50052,0.00730860108124975,0.0170357817421197,-0.0260815311333049,0.0406987332958044,0.667916124712114
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,50211,-0.00420283974065576,0.00881613838989513,-0.0214824709848502,0.0130767915035387,0.633564735280955
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20110#9.Illnesses of mother_Diabetes,50065,-0.00723415038706092,0.0139266828375393,-0.034530448748638,0.0200621479745162,0.603454714856741
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,46579,0.00693033252428209,0.014364690507693,-0.0212244608707963,0.0350851259193604,0.62948675125677
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,46436,-0.0524270146324538,0.0559330348665909,-0.162055762970972,0.0572017337060644,0.348605540150441
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,46432,0.0438598339866078,0.0590916927296143,-0.0719598837634363,0.159679551736652,0.457953805492557
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,46496,-0.0120199638371075,0.015835217609413,-0.0430569903515569,0.0190170626773419,0.447821625506829
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,46448,-0.0088901312009496,0.0333798449220003,-0.0743146272480702,0.056534364846171,0.789985788153398
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20111#2.Illnesses of siblings_Stroke,46463,0.0199447865905138,0.0244879243157203,-0.0280515450682979,0.0679411182493256,0.415382063985642
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,46442,-0.0489758276665306,0.0297897251751704,-0.107363689009865,0.00941203367680343,0.10017996174927
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,46439,0.0135896926662099,0.0290163182789294,-0.0432822911604918,0.0704616764929115,0.639541424708304
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,46460,-0.00318038920651969,0.0211423478545637,-0.0446193910014646,0.0382586125884252,0.8804287742788
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,46462,0.004514265747188,0.0255844595110313,-0.0456312748944333,0.0546598063888093,0.859945492901894
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,46648,-0.012427523130253,0.0105814866883834,-0.0331672370394844,0.00831219077897842,0.24022379276963
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,46535,0.0178621508652866,0.0152074056291785,-0.0119443641679032,0.0476686658984765,0.240179761304572
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20127.Neuroticism score,46110,0.0272121414463442,0.0177990906538839,-0.00767407623526814,0.0620983591279566,0.126316221620756
PLA2G10,Group 10 secretory phospholipase A2,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,33298,0.0340954172655393,0.0281331176599446,-0.0210454933479521,0.0892363278790308,0.225570934349178
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X20161.Pack years of smoking,31769,-0.00188525184765398,0.00871817564423753,-0.0189728761103595,0.0152023724150516,0.828803703573598
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,31769,-0.00276722526152522,0.0086014333846483,-0.0196260346954359,0.0140915841723854,0.747676469962423
PLA2G10,Group 10 secretory phospholipase A2,Cognitive function,X20191.Fluid intelligence score,31462,0.0153659621514447,0.0324700908985128,-0.0482754160096405,0.0790073403125299,0.636060758890513
PLA2G10,Group 10 secretory phospholipase A2,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,31462,-0.0335818505447727,0.0330837487312864,-0.098425998058094,0.0312622969685487,0.310114328871115
PLA2G10,Group 10 secretory phospholipase A2,Cognitive function,X20240.Maximum digits remembered correctly,30722,-0.0528496350958377,0.0346404283181031,-0.12074487459932,0.0150456044076444,0.127144205417823
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X20255.Spirometry QC measure,45650,0.0196610384572842,0.0234563517508998,-0.0263134109744794,0.0656354878890479,0.401929646380211
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X20261.avMSE,30442,-0.0046864074349921,0.00878446814575902,-0.0219039650006798,0.0125311501306956,0.593715681159189
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X20262.Myopia diagnosis,30442,0.0662743204687649,0.0419653795122904,-0.0159778233753242,0.148526464312854,0.114328832234131
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X20280.Glucose-lactate,40183,-0.0083356142023572,0.00568351627359438,-0.0194753060986022,0.00280407769388778,0.142496784834685
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X20281.Spectrometer-corrected alanine,40221,0.0320493001848546,0.00543498170071107,0.0213967360514609,0.0427018643182483,3.78066173761752e-09
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,33099,0.041185672067714,0.0261544845362634,-0.0100771176233623,0.0924484617587903,0.115360479172434
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,33096,-0.0400886945395681,0.0488288802112265,-0.135793299753572,0.0556159106744359,0.411666764348214
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),33095,0.0137953377598341,0.0609392886287177,-0.105645667952453,0.133236343472121,0.820912490937084
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),33095,0.0476895674684118,0.0244858414568993,-0.000302681787110827,0.0956818167239345,0.051490568883279
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),33095,-0.0855400435039063,0.04827553148542,-0.18016008521533,0.00907999820751684,0.0764442196402104
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,33102,0.0409573143490353,0.0597518145519618,-0.0761562421728098,0.158070870870881,0.493073798536731
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,33102,0.00262808631552837,0.0392524843278509,-0.0743067829670594,0.0795629555981161,0.946620368354137
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,33102,0.00807741197140257,0.0435098100795294,-0.0772018157844751,0.0933566397272802,0.852726915032116
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,33102,0.0429599245902255,0.071857688960513,-0.0978811457723799,0.183800994952831,0.549957484567485
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,33102,0.0217626739242505,0.0869054989659945,-0.148572104049099,0.1920974518976,0.802270301331603
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,33102,0.0194388259741693,0.0449985021095007,-0.0687582381604521,0.107635890108791,0.665760691608302
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,33102,-0.0505917566178434,0.0876787818102595,-0.222442168965952,0.121258655730265,0.563946000245438
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,33102,-0.0952707395817149,0.0601850786027662,-0.213233493643137,0.022692014479707,0.113466505718713
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),33101,-0.0384403171132437,0.0702843246932509,-0.176197593512016,0.0993169592855281,0.584443755443977
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),33101,0.0579346889450452,0.0328839306957361,-0.00651781521859759,0.122387193108688,0.0781395497304928
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),33101,-0.00350696650005136,0.0533168659169086,-0.108008023697192,0.10099409069709,0.947557739146196
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,33103,0.068358668847005,0.0789843091420634,-0.0864505770714393,0.223167914765449,0.386804049200949
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20600.Liking for adding salt to foods,34959,-0.0653858012743471,0.0264593222970723,-0.117246072976609,-0.0135255295720855,0.0134824794900272
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20601.Liking for aniseed,34959,0.049761731452909,0.0261678920739002,-0.00152733701193546,0.101050799917753,0.0572464782076246
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20602.Liking for apple juice,34959,-0.0296033868487462,0.0262778004917268,-0.0811078758125307,0.0219011021150383,0.259956435748847
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20603.Liking for apples,34959,0.00216481293797577,0.0268338944095701,-0.0504296201047816,0.0547592459807331,0.935702297578058
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20604.Liking for asparagus,34959,-0.0216395123858702,0.0269567149186079,-0.0744746736263417,0.0311956488546013,0.422137216435509
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20605.Liking for aubergine,34959,0.0039262398412924,0.0263054877148603,-0.0476325160798338,0.0554849957624186,0.881354861158001
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20606.Liking for avocados,34959,-0.0971307266446687,0.0269140188026398,-0.149882203497843,-0.0443792497914947,0.000308896730875773
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20607.Liking for bacon,34959,-0.0224358812022505,0.0264210673476602,-0.0742211732036645,0.0293494107991635,0.395808100410181
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20608.Liking for baked or steamed fish,34959,-0.0112256912096826,0.0270180153071349,-0.0641810012116671,0.0417296187923019,0.677792375361399
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20609.Liking for bananas,34959,0.0507917566443425,0.0274641461856061,-0.00303796987944537,0.10462148316813,0.0644304530339317
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20610.Liking for barbequed or grilled meat,34959,-0.0371081303688848,0.0264345602316518,-0.0889198684229223,0.0147036076851528,0.16041594110172
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20611.Liking for beef steak,34959,-0.0447495363071756,0.026398344712621,-0.0964902919439129,0.00699121932956161,0.0900738784406798
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20612.Liking for beetroot,34959,-0.0243068893963907,0.0268881132136947,-0.0770075912952323,0.028393812502451,0.366015453716566
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20613.Liking for bell pepper,34959,-0.0228376517550654,0.0265550119345864,-0.0748854751468547,0.0292101716367238,0.389801592672322
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20614.Liking for bicycling,34959,-0.0284322566946314,0.0262651525024216,-0.0799119555993779,0.023047442210115,0.279051404884233
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20615.Liking for biscuits,34959,0.0438434647686466,0.0264942998155468,-0.00808536286982511,0.0957722924071183,0.0979896254587088
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20616.Liking for bitter foods,34959,-0.0113053505642861,0.0262332128973261,-0.0627224478430452,0.040111746714473,0.666509487314679
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20617.Liking for bitter or ale,34959,-0.0378809700280939,0.0273759127102443,-0.0915377589401726,0.0157758188839849,0.166469463296015
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20618.Liking for black olives,34959,-0.021932470599518,0.0267853376459265,-0.074431732385534,0.0305667911864981,0.412905565627037
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20619.Liking for black pepper,34959,-0.0575526181873346,0.0266507352599959,-0.109788059296927,-0.00531717707774265,0.0308329367676753
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20620.Liking for blue cheese,34959,0.00876002651039598,0.0265345984644398,-0.043247786479906,0.060767839500698,0.741303781277178
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20621.Liking for bolognese sauce,34959,-0.00534195608676803,0.026566966601656,-0.0574132106260138,0.0467292984524777,0.840643728881012
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20622.Liking for broad beans,34959,0.0294860653379393,0.0264144825311907,-0.0222863204231944,0.0812584510990731,0.264326119344668
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20623.Liking for broccoli,34959,-0.0207897676894138,0.0276612236081068,-0.0750057659613032,0.0334262305824756,0.452317364195242
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20624.Liking for brown rice,34959,0.00275797672949149,0.0264476945932864,-0.0490795046733498,0.0545954581323328,0.916948806968039
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20625.Liking for brussel sprouts,34959,0.00504563051696646,0.0267112402311751,-0.0473084003361368,0.0573996613700697,0.850178447214342
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20626.Liking for burgers (meat),34959,-0.0519985238172686,0.0262749854898254,-0.103497495377326,-0.00049955225721085,0.047840690734089
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20627.Liking for burn of spicy foods,34959,-0.0812140470719366,0.0266086218526332,-0.133366945903098,-0.0290611482407755,0.00227761037900431
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20628.Liking for butter on bread,34959,0.0213668077845841,0.0268238266551807,-0.03120789245957,0.0739415080287382,0.425724186867743
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20629.Liking for butternut squash,34959,0.0589997420878733,0.0266342092239358,0.00679669200895924,0.111202792166787,0.0267686445542968
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20630.Liking for cabbage,34959,-0.0227030666707485,0.0267626664471423,-0.0751578929071474,0.0297517595656505,0.39628408601034
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20631.Liking for cake,34959,0.0919655220231886,0.0265708899190092,0.0398865777819306,0.144044466264447,0.000540036943846181
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20632.Liking for cake icing,34959,0.0167695443284829,0.0262749538271974,-0.034729365172824,0.0682684538297899,0.523335897653211
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20633.Liking for capers,34959,-0.0594039704545675,0.0262674963385609,-0.110888263278147,-0.00791967763098802,0.0237486184720058
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20634.Liking for cauliflower,34959,-0.00213923304836049,0.0270729263604551,-0.0552021687148525,0.0509237026181316,0.937020265770391
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20635.Liking for cereal or granola bar,34959,0.0362139018779936,0.026166960833171,-0.0150733413550217,0.0875011451110088,0.166401590088922
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20636.Liking for cheesecake,34959,0.0597327079120987,0.026390890622247,0.00800656229249462,0.111458853531703,0.023632384524831
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20637.Liking for cherries,34959,-0.0232666726939483,0.0286803445446969,-0.0794801480015541,0.0329468026136576,0.417245650232671
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20638.Liking for chicken,34959,-0.048266464372873,0.0279577579027869,-0.103063669862335,0.00653074111658937,0.0843036671683411
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20639.Liking for chilli pepper,34959,-0.124940682520471,0.0264588597960859,-0.1768000477208,-0.073081317320143,2.36475451714332e-06
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20640.Liking for chips or french fries,34959,-0.034404284516433,0.0265441284759734,-0.0864307763293408,0.0176222072964748,0.194963823186145
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20641.Liking for cigarette smoking,34959,0.0623071843649628,0.0435445070744412,-0.0230400495009419,0.147654418230868,0.152492926359046
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20642.Liking for cod,34959,-0.0336956687413685,0.0271378926094434,-0.0868859382558775,0.0194946007731405,0.214394766037806
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20643.Liking for coffee with sugar,34959,-0.0171317647138243,0.0299789067562976,-0.0758904219561676,0.0416268925285191,0.567699679601443
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20644.Liking for coffee without sugar,34959,0.0683062706136831,0.0270547689071974,0.0152789235555763,0.12133361767179,0.0115929854049946
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20645.Liking for coriander,34959,-0.0379299871602477,0.0264479487678533,-0.0897679667452402,0.0139079924247448,0.151562899267926
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20646.Liking for corn flakes,34959,0.0351875325485497,0.0263377342734786,-0.0164344266274684,0.0868094917245678,0.181574267329991
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20647.Liking for cream,34959,0.0508695350353335,0.0264570648856089,-0.000986312140459904,0.102725382211127,0.0545422132142475
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20648.Liking for croissant,34959,0.0424726415677396,0.0265878306280443,-0.00963950646322716,0.0945847895987064,0.110196272801485
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20649.Liking for cucumber,34959,0.0275760043371561,0.0268067174248858,-0.0249651618156201,0.0801171704899322,0.303645525359027
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20650.Liking for curry,34959,-0.102723718905199,0.0266138739369164,-0.154886911821555,-0.0505605259888426,0.000114168833933441
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20651.Liking for dairy products,34959,0.0363716894972494,0.0268978746815486,-0.0163481448785859,0.0890915238730846,0.176335913796532
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20652.Liking for dark chocolate,34959,0.0422095232789069,0.026588174732725,-0.00990329919723413,0.0943223457550479,0.112422788916903
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20653.Liking for diet fizzy drinks,34959,-0.0820302527796414,0.0275278089406595,-0.135984758303334,-0.0280757472559488,0.00288998205819437
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20654.Liking for dried fruit,34959,0.0403693118623869,0.0264382431099221,-0.0114496446330604,0.0921882683578342,0.126808871255795
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20655.Liking for eggs,34959,0.0315936986214226,0.0272941466006567,-0.0219028287158646,0.0850902259587098,0.247083644533345
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20656.Liking for exercising alone,34959,-0.0107997021447383,0.0263695873502703,-0.0624840933512681,0.0408846890617915,0.682143390016717
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20657.Liking for exercising with others,34959,-0.034514593586081,0.0264399197275568,-0.0863368362520923,0.0173076490799303,0.191786285736872
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20658.Liking for extra virgin olive oil,34959,-0.0536917326918836,0.0268334791270965,-0.106285351780993,-0.00109811360277441,0.0454263592772472
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20659.Liking for fatty foods,34959,-0.00835107448866546,0.0264193646643069,-0.0601330292307069,0.043430880253376,0.751935381237817
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20660.Liking for fresh tomatoes,34959,-0.0177625897514825,0.0289943367560389,-0.0745914897933187,0.0390663102903537,0.540139094666202
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20661.Liking for fried chicken,34959,-0.0440748620825698,0.0260799249516662,-0.0951915149878355,0.00704179082269592,0.0910591933016758
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20662.Liking for fried or battered fish,34959,0.00612161852095216,0.026447578454938,-0.0457156352507264,0.0579588722926307,0.816960146832742
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20663.Liking for fruit,34959,0.00606957065663668,0.030686759809323,-0.0540764785696364,0.0662156198829097,0.843212271026659
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20664.Liking for garlic,34959,-0.0553793751986455,0.026763069471488,-0.107834991362762,-0.00292375903452907,0.038547418224913
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20665.Liking for gherkins,34959,-0.0408669787717809,0.0264061432955989,-0.0926230196311549,0.010889062087593,0.121741189760196
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20666.Liking for globe artichoke,34959,-0.0573189705683205,0.0263546355256205,-0.108974056198537,-0.00566388493810435,0.0296590792762302
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20667.Liking for goat's cheese,34959,-0.0183394983984204,0.026322291216284,-0.069931189182337,0.0332521923854963,0.485987957703698
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20668.Liking for going to a cafe,34959,0.085238294973451,0.0268048319537297,0.0327008243441408,0.137775765602761,0.00147723438554042
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20669.Liking for going to the gym,34959,-0.0594419373011137,0.0262559234827268,-0.110903547327258,-0.00798032727496914,0.0235978833847903
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20670.Liking for going to the pub,34959,-0.17518220302913,0.0263923745269422,-0.226911257101937,-0.123453148956323,3.34550467987106e-11
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20671.Liking for grapefruit,34959,-0.00332712020217417,0.0262237139842119,-0.0547255996112296,0.0480713592068812,0.899042171436123
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20672.Liking for green olives,34959,-0.0372506353715492,0.0267623774885703,-0.0897048952491471,0.0152036245060487,0.163981239546222
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20673.Liking for haddock,34959,-0.0158324229220547,0.0270019125697368,-0.0687561715587387,0.0370913257146294,0.557656639148052
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20674.Liking for ham,34959,-0.00930735941769042,0.0264643942618501,-0.0611775721709167,0.0425628533355358,0.725075081763955
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20675.Liking for hard cheese,34959,0.0242853654145031,0.0271642674835848,-0.0289565988533231,0.0775273296823293,0.371332335392603
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20676.Liking for herring,34959,0.0363363367011626,0.0262179258087821,-0.0150507978840504,0.0877234712863756,0.165796240568526
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20677.Liking for honey,34959,0.0196268898717221,0.0262613017615151,-0.0318452615808474,0.0710990413242916,0.454857430025717
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20678.Liking for horseradish or wasabi,34959,-0.0483321291922709,0.0262806517393866,-0.0998422066014686,0.00317794821692686,0.0659321591106583
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20679.Liking for ice cream,34959,0.0339543300722669,0.0264909746323125,-0.0179679802070656,0.0858766403515994,0.199964980034926
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20680.Liking for jam,34959,0.00939177071875589,0.0265451308218412,-0.0426366856920529,0.0614202271295646,0.723492958217299
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20681.Liking for kiwi fruit,34959,0.00564895043812311,0.0264334552308424,-0.0461606218143279,0.0574585226905742,0.830781589930602
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20682.Liking for lager,34959,-0.0754524029310187,0.0265755258126891,-0.127540433523889,-0.023364372338148,0.00453181113140402
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20683.Liking for lamb,34959,-0.0216341597230598,0.0265926104065294,-0.0737556761198574,0.0304873566737379,0.415926812614444
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20684.Liking for lemons,34959,-0.041871999203035,0.0265720912821492,-0.0939532981160475,0.0102092997099775,0.115104656859584
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20685.Liking for lentils or beans,34959,0.0242119645163535,0.0267287991913907,-0.0281764818987723,0.0766004109314792,0.365042343874042
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20686.Liking for liver,34959,0.0429177659729868,0.0267046297306941,-0.00942330829917355,0.0952588402451472,0.108056301871297
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20687.Liking for mackerel,34959,0.00849424617811341,0.0264569173245814,-0.0433613117780661,0.0603498041342929,0.748171648440488
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20688.Liking for marzipan,34959,0.0903618148112955,0.0261798127611777,0.0390493817993872,0.141674247823204,0.000559501715866311
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20689.Liking for mayonnaise,34959,-0.0224813941975511,0.0263467133143943,-0.074120952293764,0.0291581638986618,0.393517821002526
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20690.Liking for melon,34959,0.0310966756241927,0.0279230907641914,-0.0236325822736224,0.0858259335220078,0.265452934164048
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20691.Liking for milk chocolate,34959,-0.0262092559024867,0.0265873917471863,-0.0783205437269718,0.0259020319219985,0.324264966213604
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20692.Liking for mushrooms,34959,0.053280821893821,0.0274324304924559,-0.000486741871392617,0.107048385659035,0.0521327419500947
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20694.Liking for orange juice,34959,-0.0332239513287829,0.0264425326570795,-0.0850513153366588,0.0186034126790929,0.20897765307296
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20695.Liking for oranges,34959,0.00346025368734302,0.0270480613454466,-0.0495539465497322,0.0564744539244183,0.898206960392497
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20696.Liking for pasta,34959,0.031147925675731,0.0268646161776569,-0.0215067220324764,0.0838025733839385,0.246303021374634
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20697.Liking for pears,34959,0.037152172709306,0.0271557972934248,-0.0160731899858066,0.0903775354044187,0.171306295701335
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20698.Liking for pizza,34959,-0.0370578137686906,0.0265054959344029,-0.0890085858001203,0.0148929582627392,0.162107140269192
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20699.Liking for plain yogurt,34959,0.0359173395578359,0.0265929272265051,-0.0162047978061141,0.0880394769217859,0.176841479989765
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20700.Liking for plums,34959,0.0286398914953441,0.026982927100445,-0.024246645621528,0.0815264286122162,0.288528993608194
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20701.Liking for pollock,34959,0.0169746047089271,0.026260230368712,-0.0344954468137484,0.0684446562316026,0.518034673233003
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20702.Liking for pork chop,34959,-0.0319257997772756,0.0263865780986111,-0.0836434928505535,0.0197918932960022,0.226334636354671
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20703.Liking for porridge,34959,0.0693257359142209,0.0271193860049745,0.0161717393444708,0.122479732483971,0.0105926325721129
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20704.Liking for potato crisps,34959,-0.0267079057923349,0.0265778118345507,-0.0788004169880543,0.0253846054033845,0.31497065381483
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20705.Liking for potatoes,34959,0.00638529731117365,0.0266819418677108,-0.0459113087495394,0.0586819033718867,0.810868668346725
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20706.Liking for prawns,34959,-0.0331909582460822,0.0270115934597514,-0.0861336814271949,0.0197517649350305,0.219186671296418
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20707.Liking for raw carrots,34959,0.0261051961365048,0.0268079835275102,-0.0264384515774153,0.0786488438504248,0.330186037546218
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20708.Liking for red meat,34959,-0.0318967269984155,0.0264937221327242,-0.083824422378555,0.0200309683817239,0.228641736114869
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20709.Liking for red wine,34959,-0.103859217782728,0.0263140061323682,-0.15543466980217,-0.0522837657632862,7.96799255657935e-05
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,34959,-0.0587033182074407,0.0278155737278197,-0.113221842713967,-0.00418479370091405,0.0348433869736589
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20711.Liking for roast chicken,34959,-0.0346157995152706,0.0280402617877627,-0.0895747126192855,0.0203431135887443,0.21704299922976
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20712.Liking for salad dressing,34959,-0.0212024842556506,0.0262085443849977,-0.0725712312502461,0.0301662627389448,0.418538487311804
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20713.Liking for salad leaves,34959,-0.0345701943470862,0.0274140243755744,-0.088301682123212,0.0191612934290397,0.207322287610351
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20714.Liking for salami,34959,-0.00245375276202819,0.0265237300330062,-0.0544402636267204,0.049532758102664,0.926293338772772
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20715.Liking for salmon,34959,0.00451579388897502,0.0283226300834075,-0.0509965610745036,0.0600281488524536,0.873324355055543
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20716.Liking for salty foods,34959,-0.0626972045411761,0.0263160175642884,-0.114276598967181,-0.0111178101151708,0.0172144817802575
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20717.Liking for salty pretzels,34959,-0.00873920121505192,0.0264966065805238,-0.0606725501128785,0.0431941476827746,0.741539976119072
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20718.Liking for sardines,34959,0.0455563355181812,0.026344541342169,-0.00607896551247005,0.0971916365488324,0.083793503964384
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20719.Liking for sausages (meat),34959,0.0151369386321846,0.026267100057758,-0.036346577481021,0.0666204547453903,0.564445131554485
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20720.Liking for savoury biscuits,34959,-0.00683100074247646,0.0267688761628645,-0.0592979980216909,0.045635996536738,0.798585645369901
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20721.Liking for shellfish (other than prawns),34959,-0.0562436977538575,0.0264832818333682,-0.108150930147259,-0.00433646536045582,0.0337149152512507
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20722.Liking for skimmed milk,34959,-0.0593478861408884,0.0264520145859073,-0.111193834729267,-0.00750193755251009,0.0248785563277526
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20723.Liking for smoked fish,34959,0.0084881129902799,0.0267434993391266,-0.0439291457144083,0.0609053716949681,0.750954183888821
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20724.Liking for soft cheese,34959,-0.0457131735676769,0.0265837348151809,-0.0978172938054314,0.00639094667007769,0.0855361352275658
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20725.Liking for soy sauce,34959,-0.0437582180478771,0.0264728796579006,-0.0956450621773623,0.00812862608160798,0.0983719290479572
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20726.Liking for soya milk,34959,0.0196903459316172,0.0264499990142576,-0.0321516521363277,0.0715323439995621,0.456629078823673
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20727.Liking for spicy foods,34959,-0.114022817856054,0.0265191531805177,-0.166000358089869,-0.0620452776222394,1.72620940774135e-05
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20728.Liking for spinach,34959,-0.00698074639568876,0.0268302439940978,-0.0595680246241204,0.0456065318327429,0.794728495017108
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20729.Liking for spirits,34959,-0.169287818195875,0.0264297049493816,-0.221090039896663,-0.117485596495087,1.56589270636352e-10
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20730.Liking for strawberries,34959,-0.00753577584461336,0.0301404840906464,-0.0666111246622804,0.0515395729730536,0.802575439649285
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20731.Liking for sweet coffee house drinks,34959,-0.0489743684313854,0.0272561660559532,-0.102396453901054,0.00444771703828298,0.0723932600271865
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20732.Liking for sweet foods,34959,0.0377346865842917,0.0264104556684458,-0.0140298065258621,0.0894991796944454,0.1530977096758
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20733.Liking for taking the stairs,34959,-0.0676258614912251,0.027038885902064,-0.12062207785927,-0.0146296451231797,0.0123973509746806
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20734.Liking for tea with sugar,34959,-0.0390300381745435,0.0351475802978135,-0.107919295558258,0.0298592192091709,0.266825601130617
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20735.Liking for tea without sugar,34959,0.0787341755335976,0.028308612395466,0.0232492952384843,0.134219055828711,0.00542415747818148
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20736.Liking for tomato ketchup,34959,-0.0255043911516705,0.0259777777573896,-0.0764208355561541,0.0254120532528131,0.326232224323366
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20737.Liking for tinned tuna,34959,-0.0151602774587938,0.0265262220878291,-0.0671516727509387,0.0368311178333512,0.567659161259068
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20738.Liking for turnip (white),34959,0.00520597371657135,0.0261293966966973,-0.0460076438089554,0.0564195912420981,0.842080285115062
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20739.Liking for vegetables,34959,0.0171446960058411,0.0305178553821602,-0.0426703005431928,0.076959692554875,0.574269535726658
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20740.Liking for vinegar,34959,-0.0305310155787465,0.0262640977226697,-0.0820086471151792,0.0209466159576861,0.245074276575152
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20741.Liking for watching television,34959,-0.0739243462674668,0.0265559357909898,-0.125973980417807,-0.0218747121171268,0.00538351780848481
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20742.Liking for whisky,34959,-0.0613014374279534,0.0279757314162729,-0.116133871003848,-0.00646900385205847,0.028456597332061
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20743.Liking for white bread,34959,-0.0221490499189563,0.0263383047142002,-0.0737721271587887,0.0294740273208761,0.400398235365413
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20744.Liking for white rice,34959,-0.00633600237803619,0.0264951796446421,-0.0582665544815346,0.0455945497254623,0.811003300269753
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20745.Liking for white wine,34959,-0.137086505330872,0.02646577037075,-0.188959415257542,-0.085213595404202,2.26283219891039e-07
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,34959,0.0508478514571933,0.0267890917368087,-0.00165876834695176,0.103354471261338,0.0577128870348119
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20747.Liking for whole milk,34959,0.0443522489309541,0.0261376882754062,-0.00687762008884208,0.0955821179507502,0.0897509583687278
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20748.Liking for wholemeal bread,34959,-0.0316620389459166,0.0279623475544629,-0.0864682401526639,0.0231441622608306,0.257530091496661
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X20749.Liking for working up a sweat,34959,-0.0914033535818286,0.0262787871265275,-0.142909776349822,-0.0398969308138348,0.000506804714310042
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X21001.Body mass index (BMI),51924,-0.200684442241993,0.0158780365968822,-0.231805393971882,-0.169563490512103,1.62390027578626e-36
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X21002.Weight,51932,-0.066047827886001,0.00977930970345847,-0.0852152749047796,-0.0468803808672224,1.46858184902077e-11
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X21021.Pulse wave Arterial Stiffness index,33530,-0.014542531563484,0.00706731653037918,-0.0283944719630271,-0.000690591163940766,0.039645877636109
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,34372,-0.00864306698637424,0.0279161993754046,-0.0633588177621672,0.0460726837894188,0.756865896121327
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,34386,-0.0466020605551772,0.0290050827592901,-0.103452022763386,0.0102479016530313,0.108155057061504
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,34387,0.0177989412829951,0.02922069163806,-0.0394736143276024,0.0750714968935926,0.542458072023528
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21040.Satisfaction with bowel habits,34339,0.0666599142777608,0.0271553450751109,0.0134354379305435,0.119884390624978,0.0141149022595119
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,34319,0.0363839985000635,0.0282137847799534,-0.0189150196686451,0.0916830166687722,0.197225965786042
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21042.Greatest number of times bowels opened per day,34331,0.00220919629266626,0.0291718717057086,-0.0549676722505226,0.0593860648358551,0.93963515661987
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21043.Least number of times bowels opened per week,34242,-0.021607065207125,0.0287054398648658,-0.077869727342262,0.0346555969280119,0.451638246747771
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21044.Average number of times bowels opened per day,34291,0.0143991636692819,0.032796004182592,-0.0498810045285984,0.0786793318671621,0.660633232462715
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,34390,0.0154308185257812,0.0292129255517274,-0.0418265155556045,0.0726881526071668,0.59735922932507
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,34384,0.0132489307667369,0.0296813596508536,-0.044926534148936,0.0714243956824099,0.655338216988915
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21050.Degree bothered by menstrual cramps or other problems with period in the last 3 months,34387,-0.0353403836932601,0.0344420789164696,-0.10284685836954,0.0321660909830203,0.304878105544354
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,34388,-0.0504633738498891,0.0306826398623648,-0.110601347980124,0.0096746002803459,0.100065777190786
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,34384,-0.071298115397305,0.0459029818352758,-0.161267959794445,0.0186717289998355,0.120398881368399
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,34385,-0.0244213860573199,0.0336069298472273,-0.0902909685578855,0.0414481964432456,0.467440915550611
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,34385,-0.0914120743069908,0.0852955257384813,-0.258591304754414,0.0757671561404325,0.283876314583819
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,34389,0.00824136755803682,0.0319977761507106,-0.0544742736973559,0.0709570088134295,0.796751346983245
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,34388,-0.0888541225645851,0.0336974861046603,-0.154901195329719,-0.0228070497994509,0.00838180504029864
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,34127,0.0268871854595526,0.0297619933387941,-0.0314463214844837,0.085220692403589,0.366332559402378
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,34385,-0.0503204149578905,0.0302178639170281,-0.109547428235266,0.0089065983194847,0.095893655955788
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,34387,-0.0444520807156679,0.0398991517820944,-0.122654418208573,0.0337502567772372,0.265258558677891
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,34389,-0.01401288402655,0.0295231001451547,-0.0718781603110532,0.0438523922579532,0.63505306156927
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,34387,0.0126686517197669,0.0295327125304598,-0.0452154648399344,0.0705527682794682,0.667954259804788
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X21100.Water hardness (USGS classification),51790,0.0271479356304029,0.0170952756578437,-0.00635880465897071,0.0606546759197765,0.112289467203482
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X2139.Age first had sexual intercourse,48142,0.0301344558302737,0.00498761621788208,0.0203587280432248,0.0399101836173226,1.54624988948631e-09
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X2149.Lifetime number of sexual partners,46630,-0.0882440799514121,0.0192896521503749,-0.126051798166147,-0.0504363617366773,4.79518582909133e-06
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X22032.IPAQ activity group,45715,-0.0157883862462229,0.0193927387487534,-0.0537981541937796,0.0222213817013338,0.415574404874789
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X22033.Summed days activity,46397,-0.00559079538078747,0.00473184041489438,-0.0148652025939805,0.00368361183240552,0.237406391065726
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X22034.Summed minutes activity,45715,-0.00869135214633778,0.00475586439291098,-0.0180128463564433,0.000630142063767741,0.0676383188851767
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X22037.MET minutes per week for walking,44678,-0.00695789541610214,0.0048074078562843,-0.0163804148144194,0.00246462398221509,0.147820612897304
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X22038.MET minutes per week for moderate activity,45715,-0.00273752616426289,0.00469976901081616,-0.0119490734254626,0.00647402109693679,0.560248910587078
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X22039.MET minutes per week for vigorous activity,45715,-0.0371509653280089,0.0193826022021245,-0.0751408656441729,0.000838934988155231,0.0552872692143027
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X22040.Summed MET minutes per week for all activity,44678,-0.00619792485693758,0.00489845019061632,-0.0157988872305456,0.00340303751667041,0.205784540020479
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X2217.Age started wearing glasses or contact lenses,48157,-0.00700867017433968,0.00452267769390685,-0.0158731184543971,0.00185577810571774,0.121233442342841
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X22501.Year ended full time education,31318,0.0554260220028404,0.0209527080133268,0.0143587142967199,0.0964933297089609,0.0081806468709585
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X22506.Tobacco smoking,31275,0.0700003711826863,0.0735090548641235,-0.0740773763509956,0.214078118716368,0.340994475948514
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,50141,-0.158354969346202,0.0402014942503458,-0.237149898076879,-0.0795600406155238,8.20271147122707e-05
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23098.Weight,51513,-0.0633159059393564,0.00985806292626896,-0.0826377092748435,-0.0439941026038692,1.36052267217013e-10
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23099.Body fat percentage,51514,-0.105266278142476,0.0101216668907572,-0.12510474524836,-0.0854278110365914,2.76429771717406e-25
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23100.Whole body fat mass,51505,-0.115577263292832,0.00969295773688956,-0.134575460457135,-0.0965790661285282,1.07388232845299e-32
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23101.Whole body fat-free mass,51513,0.000474060877892937,0.0081237264801544,-0.0154484430232097,0.0163965647789956,0.953466209007805
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23102.Whole body water mass,51513,0.00246405266999557,0.00815460724442053,-0.0135189775290687,0.0184470828690598,0.762527131716924
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23104.Body mass index (BMI),51513,-0.203301002957912,0.0160943510990984,-0.234845931112144,-0.171756074803679,1.78714732040152e-36
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23105.Basal metabolic rate,51511,-0.0126294096860173,0.00885461507108201,-0.029984455225338,0.00472563585330348,0.153790948568769
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23106.Impedance of whole body,51507,-0.0386675600897255,0.00664248089552374,-0.051686822644952,-0.025648297534499,5.9067233113717e-09
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23107.Impedance of leg (right),51510,-0.0841435614310197,0.00541298440208287,-0.0947530108591021,-0.0735341120029373,2.96501652574432e-54
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23108.Impedance of leg (left),51509,-0.0848384843064487,0.00535928118203183,-0.0953426754232311,-0.0743342931896663,3.44454803277188e-56
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23109.Impedance of arm (right),51500,0.0216721026389792,0.00666821894294446,0.00860239351080802,0.0347418117671503,0.0011552219111721
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23110.Impedance of arm (left),51508,0.0217209553732023,0.0066838193409381,0.00862066946496366,0.034821241281441,0.00115634562587019
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23111.Leg fat percentage (right),51509,-0.242110219890017,0.0159321325609657,-0.27333719970951,-0.210883240070524,6.12881840250891e-52
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23112.Leg fat mass (right),51508,-0.289271052285404,0.0183075255328122,-0.325153802329716,-0.253388302241092,5.4820348928427e-56
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23113.Leg fat-free mass (right),51508,0.0485140931884254,0.00824217762061547,0.0323594250520191,0.0646687613248317,4.00129641726717e-09
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23114.Leg predicted mass (right),51507,0.0487636559670013,0.00827355992205609,0.0325474785197714,0.0649798334142313,3.81619411112205e-09
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23115.Leg fat percentage (left),51504,-0.248042224060358,0.0164495595415111,-0.28028336076172,-0.215801087358997,3.59735069471187e-51
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23116.Leg fat mass (left),51504,-0.288248233187445,0.0183777003270963,-0.324268525828554,-0.252227940546337,3.37242599304962e-55
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23117.Leg fat-free mass (left),51502,0.0458302935416447,0.00845551247799478,0.0292574890847749,0.0624030979985144,6.00518961444385e-08
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23118.Leg predicted mass (left),51501,0.046175718248864,0.00848835465458756,0.0295385431258724,0.0628128933718557,5.37753258785865e-08
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23119.Arm fat percentage (right),51501,-0.0545292320171788,0.0112746589089869,-0.0766275634787932,-0.0324309005555644,1.32910209036457e-06
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23120.Arm fat mass (right),51497,-0.106916397906574,0.0101477654597357,-0.126806018207656,-0.0870267776054916,6.62120293868683e-26
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23121.Arm fat-free mass (right),51499,-0.0387846674347713,0.00790857243559063,-0.054285469408529,-0.0232838654610137,9.43863784868548e-07
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23122.Arm predicted mass (right),51498,-0.0390788495202759,0.00790528675839551,-0.0545732115667311,-0.0235844874738207,7.72380312107384e-07
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23123.Arm fat percentage (left),51495,-0.0601484548391079,0.0126247093253406,-0.0848928851167755,-0.0354040245614403,1.90451985214609e-06
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23124.Arm fat mass (left),51494,-0.104634568431733,0.0104040603238653,-0.125026526666509,-0.0842426101969574,9.41207435995911e-24
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23125.Arm fat-free mass (left),51494,-0.0469939627671622,0.00852105303370516,-0.0636952267132243,-0.0302926988211001,3.51885230442353e-08
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23126.Arm predicted mass (left),51492,-0.0454783395863756,0.00853603282655989,-0.062208963926433,-0.0287477152463182,1.00199999037438e-07
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23127.Trunk fat percentage,51490,-0.0561498925103194,0.00640248886665488,-0.0686987706889629,-0.0436010143316758,1.88941052727091e-18
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23128.Trunk fat mass,51486,-0.0697098783020887,0.00737303346109257,-0.0841610238858301,-0.0552587327183472,3.49284716256554e-21
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23129.Trunk fat-free mass,51480,-0.0172813038725516,0.00758959361756945,-0.0321569073629877,-0.00240570038211546,0.0227955847427354
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X23130.Trunk predicted mass,51477,-0.0166316991962903,0.00760218073628552,-0.03153197343941,-0.00173142495317074,0.0286960815577823
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23400.Total Cholesterol,40228,-0.161950066485916,0.00549930223201499,-0.172728698860666,-0.151171434111167,1.30600583260491e-185
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,40228,-0.192049718690038,0.00525742686196732,-0.202354275339494,-0.181745162040582,1.59640094837688e-280
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",40228,-0.177748200955104,0.00528324311362916,-0.188103357457818,-0.167393044452391,1.04058539961207e-239
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23403.VLDL Cholesterol,40228,-0.183754366238972,0.00516371922363613,-0.193875255917299,-0.173633476560645,7.31501564226861e-267
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23404.Clinical LDL Cholesterol,40228,-0.191076120356055,0.00526180713937932,-0.201389262349238,-0.180762978362871,2.23333223941007e-277
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23405.LDL Cholesterol,40228,-0.198448735732306,0.00524238721568752,-0.208723814675053,-0.188173656789558,3.21023434033288e-300
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23406.HDL Cholesterol,40228,0.0613733672683922,0.00626766262577802,0.0490887485218673,0.0736579860149172,1.41224245473815e-22
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23407.Total Triglycerides,40228,-0.160237394416893,0.00565674962300643,-0.171324623677986,-0.1491501651558,3.20808359230047e-172
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23408.Triglycerides in VLDL,40228,-0.162511131242075,0.00565422227672895,-0.173593406904464,-0.151428855579686,4.09575515600141e-177
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23409.Triglycerides in LDL,40228,-0.160071067966612,0.00563698039335609,-0.17111954953759,-0.149022586395634,4.86131935842733e-173
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23410.Triglycerides in HDL,40228,-0.083508435698616,0.00542296500780387,-0.0941374471139116,-0.0728794242833204,4.04416206575619e-53
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,40228,-0.133722696451914,0.0056486134483532,-0.144793978810686,-0.122651414093141,8.89122253614867e-122
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23412.Phospholipids in VLDL,40228,-0.185036708688248,0.00532455161094961,-0.195472829845709,-0.174600587530787,4.85885887169181e-255
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23413.Phospholipids in LDL,40228,-0.200552723467863,0.00519735204583493,-0.2107395334777,-0.190365913458027,1.66938548471629e-308
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23414.Phospholipids in HDL,40228,0.0425341936250218,0.00609086354565755,0.030596101075533,0.0544722861745106,2.99880975347011e-12
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23415.Total Esterified Cholesterol,40228,-0.158272153096933,0.00552320047621532,-0.169097626030315,-0.147446680163551,4.25035171847474e-176
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,40228,-0.177647155424879,0.00514490362444393,-0.187731166528789,-0.167563144320969,6.3766518507614e-252
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23417.Cholesteryl Esters in LDL,40228,-0.20449657287035,0.0052167765197974,-0.214721454849153,-0.194271690891547,1.66880539388061e-308
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23418.Cholesteryl Esters in HDL,40228,0.0624761417306578,0.00622521619177118,0.0502747179947863,0.0746775654665293,1.24682732099539e-23
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23419.Total Free Cholesterol,40228,-0.167621739588861,0.00544322929371586,-0.178290469004544,-0.156953010173178,2.85648456986473e-202
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23420.Free Cholesterol in VLDL,40228,-0.189773479702736,0.00524779681057349,-0.20005916145146,-0.179487797954012,3.5357307666359e-275
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23421.Free Cholesterol in LDL,40228,-0.175995680793252,0.00533786243902508,-0.186457891173741,-0.165533470412763,1.30371663834566e-230
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23422.Free Cholesterol in HDL,40228,0.0547296722467959,0.00629822729626466,0.0423851467461172,0.0670741977474747,3.98611681536759e-18
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,40228,-0.176044287944246,0.00545013914722604,-0.186726560672809,-0.165362015215683,1.05524431515224e-221
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23424.Total Lipids in VLDL,40228,-0.18307564647998,0.00544247445228077,-0.19374289640645,-0.17240839655351,1.23516957748447e-239
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23425.Total Lipids in LDL,40228,-0.201978348367062,0.00522357752658897,-0.212216560319176,-0.191740136414947,1.66884079617554e-308
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23426.Total Lipids in HDL,40228,0.0447767543392438,0.00616256981111002,0.0326981175094681,0.0568553911690194,3.87836037816042e-13
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,40228,-0.100328544816464,0.00571987557766005,-0.111539500948678,-0.0891175886842506,3.12986683547909e-68
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23428.Concentration of VLDL Particles,40228,-0.182450507151207,0.00524783231498429,-0.192736258488576,-0.172164755813838,2.97046613256975e-255
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23429.Concentration of LDL Particles,40228,-0.190457631664284,0.00521207318933628,-0.200673295115383,-0.180241968213185,1.05087980891846e-280
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23430.Concentration of HDL Particles,40228,-0.0703510878900133,0.00576131992265312,-0.0816432749384134,-0.0590589008416132,3.87498950394284e-34
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23431.Average Diameter for VLDL Particles,40228,-0.170672337085621,0.00596403590328987,-0.182361847456069,-0.158982826715173,1.22896819808318e-175
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23432.Average Diameter for LDL Particles,40228,0.0330143033890645,0.00558389441557921,0.0220698703345292,0.0439587364435998,3.44085195132815e-09
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23433.Average Diameter for HDL Particles,40228,0.226510108480693,0.00635333203416352,0.214057577693732,0.238962639267653,8.14978252590401e-268
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23434.Phosphoglycerides,40213,-0.112770135801979,0.0057057489033621,-0.123953403652568,-0.101586867951389,6.61707284755498e-86
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,40213,-0.134725055503626,0.00603938222418827,-0.146562244663035,-0.122887866344217,1.47896005861845e-108
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23436.Total Cholines,40213,-0.112594599031477,0.00571856972574866,-0.123802995693944,-0.10138620236901,2.81440111675932e-85
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23437.Phosphatidylcholines,40213,-0.101883834764836,0.00573695219570698,-0.113128261068422,-0.0906394084612508,7.00764862650372e-70
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23438.Sphingomyelins,40212,-0.113381217604106,0.00575446559263486,-0.124659970165671,-0.102102465042542,2.15427841207068e-85
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23439.Apolipoprotein B,40228,-0.187806119867158,0.0052160706900955,-0.198029618419746,-0.177582621314571,6.7013523698827e-273
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23440.Apolipoprotein A1,40228,-0.00051083520499796,0.00598428181649565,-0.0122400275653294,0.0112183571553335,0.931974029359596
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,40228,-0.162585178445912,0.00532029832308373,-0.173012963159156,-0.152157393732668,2.60140670527066e-199
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23442.Total Fatty Acids,40213,-0.171086934118546,0.00563597337117852,-0.182133441926056,-0.160040426311036,9.14898408746456e-197
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23443.Degree of Unsaturation,40213,0.0534572331305569,0.00606895417789057,0.0415620829418914,0.0653523833192224,1.40072694031996e-18
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23444.Omega-3 Fatty Acids,40213,-0.0701627616556542,0.00565431660905144,-0.081245222209395,-0.0590803011019134,3.42247047273679e-35
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23445.Omega-6 Fatty Acids,40213,-0.148105164744034,0.00547106743257163,-0.158828456911875,-0.137381872576194,8.66669466786293e-158
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,40213,-0.145728018203637,0.005527750825264,-0.156562409821154,-0.134893626586119,6.36262957072838e-150
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23447.Monounsaturated Fatty Acids,40213,-0.163442015969902,0.00581066412510832,-0.174830917655115,-0.15205311428469,6.81006690550671e-170
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23448.Saturated Fatty Acids,40213,-0.180771832214208,0.00574659562220839,-0.192035159633737,-0.16950850479468,1.03187509645006e-210
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23449.Linoleic Acid,40213,-0.127665447163991,0.005450797357349,-0.138349009984395,-0.116981884343587,2.79300648393318e-119
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23450.Docosahexaenoic Acid,40213,-0.0499945361457571,0.0059589349633175,-0.0616740486738594,-0.0383150236176548,5.27631157470682e-17
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,40213,0.0111731924100116,0.00567509265019716,5.00108156251313e-05,0.022296374004398,0.0489921391409436
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,40213,0.116107100145982,0.00627337858879126,0.103811278111952,0.128402922180013,1.12870699070784e-75
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,40213,0.127583521623765,0.00629831097152289,0.11523883211958,0.139928211127949,4.32954820377242e-90
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,40213,-0.0914716071927973,0.00623047462206589,-0.103683337452046,-0.0792598769335481,1.77456478173722e-48
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,40213,-0.0986030270605365,0.00587510596675879,-0.110118234755384,-0.0870878193656893,1.13358115489653e-62
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,40213,0.0514267434652453,0.00607706616400529,0.039515693783795,0.0633377931466957,2.84626870483092e-17
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,40213,0.0598997822767053,0.00603080148116178,0.0480794113736282,0.0717201531797824,3.52342818741382e-23
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,40213,0.113169049356758,0.00628151099337321,0.100857287809746,0.125480810903769,7.63487176303068e-72
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,40211,0.0145755702890282,0.00564868079169939,0.0035041559372974,0.025646984640759,0.00987900106945571
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23460.Alanine,40221,0.0298720117399354,0.00541156059805953,0.0192653529677387,0.0404786705121321,3.44276571140967e-08
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23461.Glutamine,40182,0.0815906487780843,0.00541993067617452,0.0709675846527822,0.0922137129033864,7.36633603824517e-51
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23462.Glycine,40207,0.0896574951141194,0.00517659897120662,0.0795113611305544,0.0998036290976844,1.37974879951059e-66
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23463.Histidine,40207,0.0351193430636214,0.00532555229376688,0.0246812605678383,0.0455574255594044,4.40272643392033e-11
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),40217,0.0462422176254344,0.00542831995900807,0.0356027105057786,0.0568817247450902,1.7576662664445e-17
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23465.Isoleucine,40224,0.0880646299630738,0.00529126158949235,0.0776937572476688,0.0984355026784788,1.13389746851738e-61
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23466.Leucine,40225,0.030610556992511,0.00543694804152036,0.0199541388311311,0.0412669751538909,1.8317475871097e-08
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23467.Valine,40217,0.036717034840182,0.00547795464696638,0.0259802437321279,0.0474538259482361,2.11556686570275e-11
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23468.Phenylalanine,40224,0.109658605491162,0.00524224487147141,0.0993838055430785,0.119933405439246,7.28978534359598e-96
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23469.Tyrosine,40208,0.0961611940971706,0.00530189419700797,0.085769481471035,0.106552906723306,8.91566872803939e-73
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23470.Glucose,40195,0.0255362884614935,0.00565383898624855,0.0144547640484464,0.0366178128745407,6.32885866723221e-06
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23471.Lactate,40194,-0.0514731246272228,0.0052932537914452,-0.0618479020584554,-0.0410983471959903,2.74471448730622e-22
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23472.Pyruvate,40183,-0.00510009862020467,0.00547061631807715,-0.0158225066036359,0.00562230936322654,0.351210640413499
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23473.Citrate,40226,0.0189344321503417,0.00543752628934295,0.00827688062322954,0.0295919836774539,0.000498700371481169
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23474.3-Hydroxybutyrate,40030,-0.0829508885045707,0.00507452513080909,-0.0928969577609565,-0.0730048192481849,1.44174910935558e-59
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23475.Acetate,40214,0.0393178156867919,0.00550848615815915,0.0285211828167999,0.0501144485567838,9.90574912122911e-13
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23476.Acetoacetate,40227,-0.0208743290853843,0.00529711911524588,-0.0312566825512662,-0.0104919756195023,8.1596166291547e-05
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23477.Acetone,40227,0.00267899746577243,0.00532566094530791,-0.00775929798703107,0.0131172929185759,0.614946211018476
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23478.Creatinine,39746,0.0338029372452239,0.00625614843398391,0.0215408863146155,0.0460649881758324,6.64589150465668e-08
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23479.Albumin,40226,-0.0332226450577005,0.00550746806077429,-0.0440172824568181,-0.0224280076585829,1.65263333895511e-09
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23480.Glycoprotein Acetyls,40228,-0.0849883095517634,0.00583218109483003,-0.0964193844976302,-0.0735572346058965,8.61426286934888e-48
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,40228,-0.122302747496874,0.00577288022524264,-0.133617592738349,-0.110987902255398,3.00811053018486e-98
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,40228,-0.114221306562708,0.0057812916751722,-0.125552638246046,-0.102889974879371,7.59475298424057e-86
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,40228,-0.121813613682232,0.0056814714399812,-0.132949297704595,-0.110677929659869,1.51754239792645e-100
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,40228,-0.147752980553726,0.00563363170266988,-0.158794898690959,-0.136711062416493,1.95457364716819e-148
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,40228,-0.159159773816737,0.00558351189528033,-0.170103457131487,-0.148216090501988,2.55510851017499e-174
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,40228,-0.127344949323314,0.00569526539864585,-0.13850766950466,-0.116182229141968,4.76597797302243e-109
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,40228,-0.0916186062968786,0.00584435771252959,-0.103073547413437,-0.0801636651803206,5.69768825494187e-55
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,40228,-0.176662270488978,0.00557110744561481,-0.187581641082383,-0.165742899895573,5.46328584908763e-214
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,40228,-0.172811939825233,0.00559145023968193,-0.183771182295009,-0.161852697355456,1.09678037332067e-203
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,40228,-0.171923471795058,0.005543210822284,-0.182788165006735,-0.161058778583382,4.58201451702676e-205
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,40228,-0.189584115959993,0.00534275861813409,-0.200055922851536,-0.179112309068451,2.05843018333982e-265
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,40228,-0.197024018244867,0.00520979137996587,-0.2072352093496,-0.186812827140134,1.14470309044423e-299
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,40228,-0.17407125374442,0.00549666417690198,-0.184844715531148,-0.163297791957692,1.90685283011644e-213
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,40228,-0.158151700540342,0.00568365584584359,-0.169291665998196,-0.147011735082489,2.15008029842461e-166
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23495.Concentration of Large VLDL Particles,40228,-0.183262970384812,0.00550622865734985,-0.194055178553218,-0.172470762216406,8.30262426992182e-235
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23496.Total Lipids in Large VLDL,40228,-0.181581221944827,0.00549711030614833,-0.192355558144878,-0.170806885744777,1.98393720629261e-231
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23497.Phospholipids in Large VLDL,40228,-0.181483377859979,0.00546640474134868,-0.192197531153022,-0.170769224566936,1.09921060171759e-233
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23498.Cholesterol in Large VLDL,40228,-0.18690759563578,0.0052914413673704,-0.197278820715826,-0.176536370555734,4.15366107957788e-263
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,40228,-0.178934959703511,0.00517511596181779,-0.189078186988674,-0.168791732418348,1.39528672352867e-252
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,40228,-0.192766128750747,0.00542179186516029,-0.203392840806462,-0.182139416695033,2.07993020056078e-266
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23501.Triglycerides in Large VLDL,40228,-0.16998853157742,0.00560763814357756,-0.180979502338832,-0.158997560816008,3.05961557474643e-196
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,40228,-0.196806488483349,0.00517853375406075,-0.206956414641308,-0.18665656232539,1.76218319717166e-302
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23503.Total Lipids in Medium VLDL,40228,-0.194388251355951,0.00524299528701484,-0.2046645221185,-0.184111980593402,1.41883427143593e-288
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23504.Phospholipids in Medium VLDL,40228,-0.191277590203128,0.00517785165731681,-0.201426179451469,-0.181129000954787,1.37902362411192e-286
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23505.Cholesterol in Medium VLDL,40228,-0.172877115588904,0.00525926921569475,-0.183185283251666,-0.162568947926142,2.86831648403057e-229
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,40228,-0.154844867212007,0.00538771869281272,-0.16540479584992,-0.144284938574095,4.23391948320588e-177
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,40228,-0.187119796963823,0.00517251066035402,-0.197257917858117,-0.176981676069529,2.26593616481229e-275
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23508.Triglycerides in Medium VLDL,40228,-0.181944646834157,0.00547746425903878,-0.192680476781873,-0.171208816886441,6.44620845334024e-234
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23509.Concentration of Small VLDL Particles,40228,-0.181074256911999,0.00525659190330375,-0.191377177042474,-0.170771336781523,8.77340616298122e-251
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23510.Total Lipids in Small VLDL,40228,-0.184720935880485,0.00521699656087199,-0.194946249139794,-0.174495622621176,2.56610004611648e-264
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23511.Phospholipids in Small VLDL,40228,-0.193270289424315,0.00513199003658884,-0.20332898989603,-0.183211588952601,2.73670301969205e-297
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23512.Cholesterol in Small VLDL,40228,-0.190883445195636,0.00507553571840114,-0.200831495203702,-0.18093539518757,1.61568521098566e-296
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,40228,-0.187530294305127,0.00505098957457895,-0.197430233871302,-0.177630354738952,2.4330323581227e-289
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,40228,-0.19307163808319,0.0051423405985028,-0.203150625656255,-0.182992650510124,1.4239176937279e-295
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23515.Triglycerides in Small VLDL,40228,-0.139168265172767,0.00550237040511754,-0.149952911166797,-0.128383619178736,2.18204731157128e-138
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,40228,-0.142820321596793,0.00536363427871681,-0.153333044783078,-0.132307598410508,7.62379948731782e-153
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,40228,-0.13238494473034,0.00537521191471895,-0.142920360083189,-0.121849529377491,1.86440911626608e-131
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,40228,-0.127163181635328,0.00537287419126771,-0.137694015050213,-0.116632348220444,1.0181298994188e-121
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,40228,-0.124504876584287,0.0054865722923681,-0.135258558277328,-0.113751194891245,3.28900815510898e-112
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,40228,-0.1162792296022,0.00553847396624432,-0.127134638576039,-0.105423820628361,1.52379110526191e-96
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,40228,-0.13862188616174,0.00538195247442504,-0.149170513011613,-0.128073259311867,2.44177987605663e-143
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,40228,-0.117196265511697,0.0054939117691754,-0.127964332579281,-0.106428198444113,1.45355312516662e-99
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23523.Concentration of IDL Particles,40228,-0.15410520619518,0.00536012575408793,-0.164611052673193,-0.143599359717168,3.22468270989983e-177
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23524.Total Lipids in IDL,40228,-0.14663592562501,0.00551910924957208,-0.157453379754171,-0.135818471495849,3.40981929435565e-152
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23525.Phospholipids in IDL,40228,-0.142484155553703,0.00554645227190268,-0.153355202006633,-0.131613109100774,1.29764691210475e-142
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23526.Cholesterol in IDL,40228,-0.139070552867738,0.0055361341280699,-0.149921375758755,-0.128219729976721,1.41473358969528e-136
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23527.Cholesteryl Esters in IDL,40228,-0.137393603934462,0.00552405940136485,-0.148220760361138,-0.126566447507787,5.64134201659289e-134
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23528.Free Cholesterol in IDL,40228,-0.140238023294071,0.00557014857940303,-0.151155514509701,-0.129320532078441,3.62788872426652e-137
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23529.Triglycerides in IDL,40228,-0.123047736921669,0.00556552394139626,-0.133956163846806,-0.112139309996533,1.07581457882556e-106
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23530.Concentration of Large LDL Particles,40228,-0.176490820790874,0.00526826233184878,-0.186816614961298,-0.166165026620451,9.22513485948389e-238
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23531.Total Lipids in Large LDL,40228,-0.189633405700522,0.00529523859560046,-0.200012073347899,-0.179254738053145,4.11131885855744e-270
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23532.Phospholipids in Large LDL,40228,-0.193403834730291,0.00526043469256533,-0.203714286727719,-0.183093382732863,5.38722589948864e-284
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23533.Cholesterol in Large LDL,40228,-0.184019389914594,0.00532350900197218,-0.19445346755846,-0.173585312270729,1.8469081030384e-252
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,40228,-0.188527558723304,0.00529086376477773,-0.198897651702268,-0.178157465744339,1.55207967827315e-267
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23535.Free Cholesterol in Large LDL,40228,-0.166308172555228,0.00541701759567883,-0.176925527042759,-0.155690818067698,4.31327520299033e-201
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23536.Triglycerides in Large LDL,40228,-0.154317167205492,0.00559879295280358,-0.165290801392987,-0.143343533017997,2.26114510915626e-163
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23537.Concentration of Medium LDL Particles,40228,-0.210212337253782,0.00515021002874582,-0.220306748910124,-0.20011792559744,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23538.Total Lipids in Medium LDL,40228,-0.223606382498803,0.00513476874117226,-0.2336705292315,-0.213542235766105,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23539.Phospholipids in Medium LDL,40228,-0.216678166768144,0.00511279982506001,-0.226699254425261,-0.206657079111026,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23540.Cholesterol in Medium LDL,40228,-0.222831743207053,0.00513597728271771,-0.232898258681179,-0.212765227732926,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,40228,-0.229515386112801,0.00513753131011011,-0.239584947480617,-0.219445824744985,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,40228,-0.194338289903696,0.00520946263093718,-0.204548836660332,-0.184127743147059,5.59746731606257e-292
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23543.Triglycerides in Medium LDL,40228,-0.17028697717133,0.00565871926184574,-0.181378066924548,-0.159195887418113,1.68985614475417e-193
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23544.Concentration of Small LDL Particles,40228,-0.186516297116695,0.00519089006993867,-0.196690441653775,-0.176342152579616,7.81104203414343e-272
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23545.Total Lipids in Small LDL,40228,-0.20167936426422,0.00520239492884875,-0.211876058324764,-0.191482670203676,1.66880642414579e-308
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23546.Phospholipids in Small LDL,40228,-0.172874983583074,0.00523812909348982,-0.183141716606314,-0.162608250559834,4.85186006620413e-231
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23547.Cholesterol in Small LDL,40228,-0.206267840651733,0.00517496273472543,-0.216410767611794,-0.196124913691671,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,40228,-0.214671684131501,0.00518971942680248,-0.224843534208034,-0.204499834054969,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23549.Free Cholesterol in Small LDL,40228,-0.16931272619723,0.0052287262476881,-0.179561029642699,-0.159064422751762,9.19597233958651e-223
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23550.Triglycerides in Small LDL,40228,-0.150203028666194,0.00574297893971327,-0.161459267388032,-0.138946789944356,1.21675610304327e-147
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,40228,0.141478880545056,0.00616393415812497,0.129397569595131,0.153560191494981,1.04046051734884e-114
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23552.Total Lipids in Very Large HDL,40228,0.175697701871063,0.0061509135808854,0.163641911252527,0.187753492489598,5.11976228241298e-175
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23553.Phospholipids in Very Large HDL,40228,0.19414155223714,0.00611979925983649,0.18214674568786,0.206136358786419,3.69799908243277e-214
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23554.Cholesterol in Very Large HDL,40228,0.157075247293824,0.00614301598595171,0.145034935961359,0.169115558626289,2.46718443460548e-141
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,40228,0.156861040515487,0.00624600901474169,0.144618862846594,0.169103218184381,1.66421491666131e-136
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,40228,0.150782948168979,0.00571879595259317,0.139574108101897,0.161991788236062,5.82487078642734e-150
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23557.Triglycerides in Very Large HDL,40228,-0.0226230219749168,0.00566173734596084,-0.033720027173,-0.0115260167768335,6.47761919123614e-05
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23558.Concentration of Large HDL Particles,40228,0.155672163073125,0.00651853672074087,0.142895831100473,0.168448495045778,7.4571395624865e-124
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23559.Total Lipids in Large HDL,40228,0.163493453821689,0.00647129720209948,0.150809711305574,0.176177196337804,4.31464155830802e-138
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23560.Phospholipids in Large HDL,40228,0.15947271287605,0.00639100965264355,0.146946333956869,0.171999091795231,8.10654250895669e-135
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23561.Cholesterol in Large HDL,40228,0.166148792548367,0.0064683967083819,0.153470734999938,0.178826850096795,1.39749074922286e-142
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,40228,0.16620519679569,0.00645083442869952,0.153561561315439,0.178848832275941,1.99748451650312e-143
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23563.Free Cholesterol in Large HDL,40228,0.162435512302289,0.00646242672831852,0.149769155914785,0.175101868689793,9.87502127628652e-137
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23564.Triglycerides in Large HDL,40228,0.0258402962629314,0.00559374268138836,0.0148765606074102,0.0368040319184526,3.87706186386949e-06
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23565.Concentration of Medium HDL Particles,40228,0.00692906392899334,0.00593595592413605,-0.00470540968231332,0.0185635375403,0.243105345814886
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23566.Total Lipids in Medium HDL,40228,0.00171485945122467,0.0058848148773834,-0.0098193777084468,0.0132490966108961,0.770746075527205
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23567.Phospholipids in Medium HDL,40228,-0.00303267591167753,0.00584896115015777,-0.0144966397659868,0.0084312879426317,0.604117977702755
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23568.Cholesterol in Medium HDL,40228,0.0202280717746827,0.00595377915650075,0.00855866462794122,0.0318974789214242,0.000681680842623574
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,40228,0.0214950163440235,0.00592410270708804,0.00988377503813091,0.033106257649916,0.000286083251540787
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,40228,0.0143236691080292,0.00602902744214964,0.00250677532141593,0.0261405628946425,0.0175235657627431
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23571.Triglycerides in Medium HDL,40228,-0.0868591405529389,0.00536881054528323,-0.0973820092216941,-0.0763362718841838,2.11116646782659e-58
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23572.Concentration of Small HDL Particles,40228,-0.198263895485822,0.005107763545424,-0.208275112034853,-0.188252678936791,1.66880557188159e-308
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23573.Total Lipids in Small HDL,40228,-0.178817999142651,0.00521635955485304,-0.189042063870163,-0.168593934415139,1.82741321287622e-248
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23574.Phospholipids in Small HDL,40228,-0.155431388998015,0.0053227064622416,-0.165863893664008,-0.144998884332021,1.28879915382351e-182
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23575.Cholesterol in Small HDL,40228,-0.1839085271361,0.00515229783922313,-0.194007030900977,-0.173810023371223,2.01540278349872e-268
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,40228,-0.180240505829193,0.00509705477751543,-0.190230733193124,-0.170250278465263,1.15416024104266e-263
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23577.Free Cholesterol in Small HDL,40228,-0.166272806506376,0.00539645373559368,-0.17684985582814,-0.155695757184612,1.74442959857569e-202
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23578.Triglycerides in Small HDL,40228,-0.156163117784588,0.00544890759180143,-0.166842976664519,-0.145483258904657,3.84754986480588e-176
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39355,-0.0405696526285595,0.00508243936942397,-0.0505312337926305,-0.0306080714644886,1.54026758377635e-15
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39355,-0.0620398166452376,0.00531909675031773,-0.0724652462758603,-0.0516143870146148,2.67507144564631e-31
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39355,-0.0854796796198546,0.0051683178642206,-0.095609582633727,-0.0753497766059823,6.68354727636452e-61
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39355,-0.00453599470080438,0.00544423226801673,-0.0152066899461172,0.0061347005445084,0.404759756712258
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39355,0.0679737224295704,0.00514322751331798,0.0578929965034672,0.0780544483556737,1.1830759778363e-39
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,39991,-0.0698357438989103,0.00495771514285438,-0.0795528655789049,-0.0601186222189157,8.69888770978853e-45
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,39991,0.0189777058639895,0.00566168869175979,0.00788079602814036,0.0300746156998387,0.000804354671893165
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,39991,0.0149783267279904,0.00567497764121067,0.00385537055121746,0.0261012829047633,0.00831448663255732
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,39991,0.0244806875313162,0.00536108947320921,0.0139729521638262,0.0349884228988063,5.00065910322231e-06
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,39991,0.00778464878183693,0.00543409265640705,-0.00286617282472089,0.0184354703883948,0.152004524976912
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,40223,-0.129216294158123,0.0052417070372786,-0.139490039951189,-0.118942548365057,1.08686317603903e-131
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,40223,-0.037890458617568,0.00525977833520081,-0.0481996241545616,-0.0275812930805744,6.11993442215671e-13
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,40223,0.00395391946055964,0.00553466657270904,-0.00689402702195008,0.0148018659430694,0.474995620972766
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,40223,-0.117017783016346,0.0049779106388037,-0.126774487868401,-0.10726107816429,3.95027255476784e-120
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,40223,0.0823748332371159,0.00493328926592314,0.0727055862759066,0.0920440801983253,4.6409633722615e-62
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,40228,-0.0515012616493634,0.00555729618548614,-0.0623935621729163,-0.0406089611258106,2.15031328007467e-20
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,40228,0.0186734947602024,0.0058183856062,0.00726945897205037,0.0300775305483544,0.00133280912363526
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,40228,0.0329467905376248,0.00585849172556963,0.0214641467555083,0.0444294343197413,1.90006865063931e-08
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,40228,-0.0215491551236966,0.00569286608990719,-0.0327071726599147,-0.0103911375874785,0.00015409717307764
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,40228,-0.00253685445178431,0.00577894961151051,-0.0138635956903449,0.0087898867867763,0.660680641868671
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,40228,-0.0398575933957784,0.00565838208101722,-0.0509480222745722,-0.0287671645169847,1.94528889043149e-12
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,40228,-0.0697693840313252,0.00552069387392374,-0.0805899440242157,-0.0589488240384347,1.96218139949502e-36
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,40228,-0.0848100573447196,0.00535479339827689,-0.0953054524053423,-0.0743146622840969,4.58861681492052e-56
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,40228,-0.0366217079442708,0.00567648732769736,-0.0477476231065576,-0.0254957927819839,1.13993805896529e-10
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,40228,0.0621602755426651,0.00557135380628071,0.051240422082355,0.0730801290029753,8.47159889743215e-29
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,40228,0.0211897763863868,0.00567596150516276,0.0100648918362677,0.0323146609365058,0.000189689980197646
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,40228,0.00241812973590336,0.00590703217778772,-0.00915965333256057,0.0139959128043673,0.682277687950847
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,40228,0.0163935662524407,0.00594212769786105,0.004746995964633,0.0280401365402483,0.00580681889856336
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,40228,-0.0968092261957594,0.00572077707241142,-0.108021949257686,-0.085596503133833,1.12110750911672e-63
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,40228,-0.00688289936156081,0.00589951501404126,-0.0184459487890817,0.00468015006596006,0.24335361588944
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,40228,0.0601018866922554,0.00527972698470024,0.049753621802243,0.0704501515822679,6.60923547092855e-30
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,40228,-0.0343876231129548,0.00560330603887821,-0.045370102949156,-0.0234051432767535,8.60915915140706e-10
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,40228,-0.0275394164433582,0.00558581154830674,-0.0384876070780394,-0.016591225808677,8.29614066916203e-07
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,40228,-0.0231523081416108,0.0057771065430367,-0.0344754369659628,-0.0118291793172589,6.16217540873325e-05
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,40228,0.0183307896104233,0.00580026266372978,0.00696227478951291,0.0296993044313336,0.00157884111604786
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,40228,-0.00275130229338124,0.00529187605676449,-0.0131233793646396,0.00762077477787716,0.603133203303057
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,40228,-0.0449954633068868,0.00580067947916414,-0.0563647950860485,-0.0336261315277251,9.23088754345856e-15
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,40228,-0.0923021153382437,0.00531227230176448,-0.102714169049702,-0.0818900616267853,5.33810457966303e-67
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,40228,0.0570109705489744,0.00579118454886757,0.045660248833194,0.0683616922647549,8.42722924193063e-23
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,40228,0.0532233732421992,0.00576550322553431,0.0419229869201519,0.0645237595642464,3.00518894416477e-20
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,40228,0.0851407472739856,0.00518948133994417,0.074969363847695,0.0953121307002762,5.40079884593752e-60
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,40228,-0.111640556561173,0.00531459767178984,-0.122057167997881,-0.101223945124465,1.20201281368625e-96
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,40228,-0.157865978733598,0.00531154030394859,-0.168276597729337,-0.147455359737859,6.3041784613281e-189
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,40228,0.0960959570705432,0.00586518047638374,0.0846002033368311,0.107591710804255,7.74301094138142e-60
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,40228,0.0850365412631663,0.00554540695615311,0.0741675436291062,0.0959055388972264,1.07736674041331e-52
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,40228,0.163241211017269,0.00518515080834798,0.153078315432907,0.173404106601631,4.81744983298205e-211
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,40228,-0.162214052065495,0.00525275324873613,-0.172509448433018,-0.151918655697972,2.25669256161028e-203
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,40228,-0.166857770562942,0.00522842440203988,-0.17710548239094,-0.156610058734944,1.25149431567062e-216
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,40228,0.0224320388559209,0.00578331328640551,0.0110967448145661,0.0337673328972757,0.000105419846167652
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,40228,0.0171651350142971,0.00572121018214132,0.00595156305730009,0.0283787069712941,0.00270167946765548
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,40226,0.238505037156989,0.00585107512604825,0.227036929909934,0.249973144404043,0
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,40226,-0.174570310235346,0.00598043099894847,-0.186291954993285,-0.162848665477407,1.76624668745305e-182
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,40226,-0.120703543307843,0.00608317039264247,-0.132626557277422,-0.108780529338264,1.46003854426656e-86
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,40226,-0.147153533318398,0.00641695055555643,-0.159730756407288,-0.134576310229507,1.64934129963728e-114
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,40226,-0.166562132742566,0.0059960088718991,-0.178314310131488,-0.154809955353643,7.46597721464662e-166
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,40228,-0.0801176803257508,0.00636183780626076,-0.0925868824260219,-0.0676484782254797,3.42442340060978e-36
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,40228,0.120576347639637,0.0062803610877432,0.10826683990766,0.132885855371614,3.1829233943025e-81
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,40228,0.105513192731818,0.00636336613998213,0.0930409950974527,0.117985390366183,3.13379438580616e-61
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,40228,0.0986029392578281,0.00610790910017579,0.0866314374214835,0.110574441094173,3.68967230812437e-58
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,40228,-0.112194332444211,0.00610696475644342,-0.12416398336684,-0.100224681521581,1.33041706850176e-74
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,40228,-0.0452141000769536,0.00600820883632548,-0.0569901893961515,-0.0334380107577556,5.53963643660685e-14
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,40228,0.0797943839387091,0.00583481578877082,0.0683581449927183,0.0912306228846999,2.47739588767159e-42
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,40228,0.0743641275584155,0.00580431454629796,0.0629876710476714,0.0857405840691595,2.16118111617548e-37
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,40228,0.054411802694979,0.0062890473020798,0.0420852699829026,0.0667383354070554,5.54981809297637e-18
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,40228,-0.0938940599955156,0.00566709998211977,-0.10500157596047,-0.0827865440305609,3.88075836406204e-61
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,40228,0.150050908765956,0.0054645859992289,0.139340320207467,0.160761497324444,3.46078704900765e-162
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,40228,-0.0411881596398144,0.00559325472946429,-0.0521509389095644,-0.0302253803700644,1.87434673043567e-13
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,40228,-0.056780834076473,0.00559893140872652,-0.0677547396375769,-0.045806928515369,4.29121616369629e-24
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,40228,0.0302924406068727,0.00570809552487767,0.0191045733781124,0.0414803078356329,1.12997258965576e-07
PLA2G10,Group 10 secretory phospholipase A2,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,40228,-0.0946888071310313,0.0056596042517041,-0.105781631464371,-0.0835959827976913,2.69782093268384e-62
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,51630,0.000124454048010201,0.00464380632075171,-0.00897740634066315,0.00922631443668355,0.978619443353466
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,51630,0.00483120972358882,0.00455002335994273,-0.00408683606189893,0.0137492555090766,0.288336431689888
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,49775,0.00630676707861637,0.00436177507127881,-0.00224231206109011,0.0148558462183228,0.148212707620096
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,49775,0.00375567959462911,0.00473557266562168,-0.00552604282998937,0.0130374020192476,0.427739675172629
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,49775,-0.000701748412905365,0.00465268392387815,-0.00982100890370653,0.0084175120778958,0.880113718160395
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,49775,0.0074510940445659,0.00426662636394221,-0.00091149362876084,0.0158136817178926,0.0807593838588815
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24009.Traffic intensity on the nearest road,51630,0.0180008616040302,0.0376242674895626,-0.0557427026755125,0.0917444258835729,0.632342675853246
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24010.Inverse distance to the nearest road,51630,0.00401225421967082,0.00406426936362576,-0.00395371373303566,0.0119782221723773,0.323552485310134
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24011.Traffic intensity on the nearest major road,51630,0.0018580544371128,0.00407471687955243,-0.00612839064680996,0.00984449952103556,0.648396526476982
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24012.Inverse distance to the nearest major road,51630,0.00037256857397694,0.00414352625614742,-0.007748742888072,0.00849388003602588,0.928354769626921
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24013.Total traffic load on major roads,51630,-0.017285564872171,0.0262981971115569,-0.0688300312108225,0.0342589014664805,0.510999471952071
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24015.Sum of road length of major roads within 100m,51630,-0.0132442475675944,0.0254752800399747,-0.0631757964459448,0.036687301310756,0.603147100469815
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,51630,-0.00223178592946402,0.00462131008966309,-0.0112895537052037,0.00682598184627565,0.629146771797051
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,51630,-0.00150207855070259,0.00461073705763758,-0.0105391231836723,0.00753496608226708,0.74459452884454
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,51630,-0.00164640347461136,0.00456825974997183,-0.0106001925845562,0.00730738563533343,0.718550391892295
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,51566,0.000969254010215008,0.00450615506048061,-0.00786280990832698,0.009801317928757,0.829694422171134
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24020.Average daytime sound level of noise pollution,51630,0.00112579258522017,0.00409594397777691,-0.00690225761122257,0.00915384278166291,0.78342937305744
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24021.Average evening sound level of noise pollution,51630,0.00105768096387723,0.00409558464296935,-0.0069696649363427,0.00908502686409716,0.796216637739968
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24022.Average night-time sound level of noise pollution,51630,0.00112472752878798,0.0040958696469939,-0.00690317697932006,0.00915263203689602,0.78362533015259
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24023.Average 16-hour sound level of noise pollution,51630,0.00115494817720443,0.00409557272662898,-0.00687237436698837,0.00918227072139723,0.777946281267956
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24024.Average 24-hour sound level of noise pollution,51630,0.00114253540586459,0.00409557473303962,-0.00688479107089307,0.00916986188262225,0.780271296424533
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",48697,-0.000199667718599202,0.00476136387292903,-0.00953194090954011,0.00913260547234171,0.966550872902425
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",48697,-0.00399830122078283,0.00434430085649146,-0.0125131308995061,0.00451652845794043,0.357396167982407
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,"X24502.Water percentage, buffer 1000m",48697,0.000103567941062297,0.00426664478622353,-0.00825905583993582,0.00846619172206041,0.980634362917389
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,"X24503.Greenspace percentage, buffer 300m",48697,0.00040584669274329,0.00448610142358606,-0.00838691209748539,0.00919860548297197,0.927916411293055
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",48697,-0.0032245591806795,0.00437676331750305,-0.0118030152829855,0.00535389692162647,0.461284468467002
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,"X24505.Water percentage, buffer 300m",48697,0.00372342574066273,0.00428748327284846,-0.00468004147412024,0.0121268929554457,0.3851616205264
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",51790,-0.00433639925439286,0.00453809592154901,-0.0132310672606289,0.00455826875184321,0.339305665738731
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,"X24507.Natural environment percentage, buffer 300m",51790,-0.00696945183811102,0.00428101718346868,-0.0153602455177096,0.00142134184148758,0.103538595302671
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X24508.Distance (Euclidean) to coast,51790,-0.00349942472735615,0.00409285893461177,-0.0115214282391952,0.00452257878448291,0.392554536959389
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X2684.Years since last breast cancer screening  or  mammogram,35576,-0.0114767925496909,0.02809837530142,-0.0665496081404741,0.0435960230410922,0.682950902850677
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X2704.Years since last cervical smear test,45375,-0.0638958385865385,0.0203984388567488,-0.103876778745766,-0.0239148984273109,0.00173629290058043
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X2714.Age when periods started (menarche),51136,-0.0138025178032822,0.0171685379030416,-0.0474528520932438,0.0198478164866793,0.421437328113535
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X2734.Number of live births,51958,-0.0495752202575584,0.0165346719379186,-0.0819831772558789,-0.0171672632592379,0.00271769964185667
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X2744.Birth weight of first child,46282,-0.0325750658878254,0.01845927482654,-0.0687552445478439,0.00360511277219308,0.0776283350393121
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X2754.Age at first live birth,43032,0.00585786288228829,0.00516377471055736,-0.00426313555040413,0.0159788613149807,0.25663519444213
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X2764.Age at last live birth,42986,0.00410407341835084,0.00499007147322233,-0.00567646666916492,0.0138846135058666,0.410832651849142
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X2794.Age started oral contraceptive pill,45548,0.0171079979861069,0.00558009518656391,0.00617101142044169,0.0280449845517722,0.00217292281581825
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X2804.Age when last used oral contraceptive pill,43592,-0.0014878036634077,0.00483327394519452,-0.010961020595989,0.00798541326917356,0.758218671970023
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X2867.Age started smoking in former smokers,30032,0.00263657605085025,0.00921442439597699,-0.0154236957652647,0.0206968478669651,0.774784788476614
PLA2G10,Group 10 secretory phospholipase A2,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",35496,0.0520722897967074,0.0306154258653762,-0.00793394489942993,0.112078524492845,0.0889990524741096
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,35489,0.0365942147486797,0.033303555727722,-0.0286807544776554,0.101869183975015,0.271875777852969
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,35526,0.0273730835284914,0.0361945291742992,-0.0435681936531351,0.0983143607101178,0.449499331648663
PLA2G10,Group 10 secretory phospholipase A2,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",35484,0.0443904578561575,0.0348032177506694,-0.0238238489351546,0.112604764647469,0.202169821085951
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X28739.Difficulty with standing for long periods,35538,0.137242653694269,0.0305040566708179,0.0774547026194662,0.197030604769072,6.89167311436314e-06
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X28740.Difficulty with taking care of household responsibilities,35567,0.11021301083797,0.0331193455800736,0.0452990935010259,0.175126928174914,0.000878337047628959
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X28741.Difficulty learning a new task,35457,0.0489251763298422,0.0368979998372864,-0.023394903351239,0.121245256010923,0.184881332310056
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X28742.Difficulty with joining in community activities,35177,0.0861403116162899,0.0390687101789499,0.00956563966554821,0.162714983567032,0.0274863764980161
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X28743.Difficulty with being emotionally affected by health problems,35490,0.0691863178110922,0.0326943858643243,0.00510532151701656,0.133267314105168,0.0343541408689635
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,35561,0.0813085421305502,0.0482179332423105,-0.0131986070243783,0.175815691285479,0.0917715434863567
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,30004,-0.00539393732011139,0.0393326022473708,-0.0824858377249581,0.0716979630847353,0.890927837227875
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X2897.Age stopped smoking,30043,-0.0100225436793647,0.0094848844978728,-0.0286129172951953,0.00856782993646602,0.290700610593879
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,34420,-0.0244507088403498,0.0135099492491765,-0.0509302093687356,0.00202879168803608,0.0703522889826133
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,34420,0.0183394826701805,0.0143959451345569,-0.00987656979355099,0.046555535133912,0.20271654116739
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,34420,0.00847286553530266,0.0477465754589728,-0.085110422364284,0.102056153434889,0.859154664191682
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,34420,-0.0260315586088305,0.0503733034429994,-0.124763233357109,0.0727001161394483,0.60532615771416
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,34420,0.0103005483367596,0.0527406639768128,-0.0930711530577936,0.113672249731313,0.845157674483999
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,34420,-0.0604647631701747,0.0439968425952441,-0.146698574656853,0.0257690483165037,0.169380151976507
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,34420,-0.00129818116153424,0.0203434082784831,-0.0411712613873611,0.0385748990642927,0.949120122673534
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,34420,-0.00432523905980138,0.0359195538348099,-0.0747275645760288,0.0660770864564261,0.904157145534941
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29002.Recent lack of interest or pleasure in doing things,34350,0.0317530800185146,0.0365578197922552,-0.0399002467743056,0.103406406811335,0.385102617338587
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29003.Recent feelings of depression,34336,0.0542373949866931,0.03495895079137,-0.0142821485643921,0.122756938537778,0.120823638085041
PLA2G10,Group 10 secretory phospholipase A2,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",34355,0.0339998622680963,0.0287215507919297,-0.0222943772840858,0.0902941018202785,0.236530443532665
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29005.Recent feelings of tiredness or low energy,34363,0.0585717775728321,0.0294233047343229,0.000902100293559097,0.116241454852105,0.0465457688189529
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29006.Recent poor appetite or overeating,34369,0.0281504575503737,0.037683358976445,-0.0457089260434586,0.102009841144206,0.455065442444057
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29007.Recent feelings of inadequacy,34323,0.0812301238604161,0.0379916685710315,0.00676645346119446,0.155693794259638,0.0325328230194116
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29008.Recent trouble concentrating on things,34370,0.0511543734231326,0.0383113391145939,-0.0239358512414713,0.126244598087737,0.181832379680782
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29009.Recent changes in speed or amount of moving or speaking,34357,0.135599107613677,0.0681417343419249,0.00204130830350435,0.26915690692385,0.0466231459377458
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29010.Recent thoughts of suicide or self-harm,34293,0.0524408173966993,0.0768306429118395,-0.0981472427105061,0.203028877503905,0.494906796205651
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29038#0.Substances taken for depression_None of options listed,33042,0.00155523223914056,0.0258841759931171,-0.0491777527073689,0.05228821718565,0.952089902851851
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),33042,-0.058553649684266,0.0525455017867753,-0.161542833186346,0.0444355338178135,0.265163752958921
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),33042,0.0405849512037893,0.0244197800768404,-0.00727781774681788,0.0884477201543965,0.0965552013160501
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),33042,0.0781324381962048,0.0699960667087187,-0.0590598525528838,0.215324728945293,0.264350464439332
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),33042,0.0312789487814832,0.0444960958200122,-0.0559333990257406,0.118491296588707,0.482100102248664
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),33042,0.0321142651728067,0.04657631246929,-0.0591753072670018,0.123403837612615,0.490528679288983
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),33042,0.0409023914767183,0.052803229204811,-0.0625919377647112,0.144396720718148,0.438586070369306
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),33042,-0.0022186256754874,0.0627248032765119,-0.125159240097451,0.120721988746476,0.971784900340749
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),33042,0.0281402553526472,0.0474698598666976,-0.06490066998608,0.121181180691374,0.553328886760925
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,33042,0.0140561942771512,0.0261745663831416,-0.0372459558338064,0.0653583443881088,0.591269591185024
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,33042,-0.00540727041977981,0.0395456881719862,-0.0829168192368727,0.0721022783973131,0.891243652673247
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,33042,0.00404326430335542,0.0617070704323252,-0.116902593744002,0.124989122350713,0.947758707163661
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,33042,0.096275924514306,0.0844588755314874,-0.0692634715274093,0.261815320556021,0.254353570432099
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,33042,0.0988660018596883,0.0529553820305975,-0.0049265469202828,0.202658550639659,0.061940099937987
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,33042,0.148493602140865,0.0922413944176685,-0.032299530917765,0.329286735199495,0.107470207877915
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,33042,-0.0445086321076442,0.0872880561684947,-0.215593222197894,0.126575957982605,0.610130992124758
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,33042,0.0146625429094008,0.0454001832142931,-0.0743218161906136,0.103646902009415,0.746731732569167
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,33042,0.061624130713977,0.0447214715345054,-0.0260299534936536,0.149278214921608,0.168253383182934
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,33042,0.081621722942426,0.0614446506123417,-0.0388097922577636,0.202053238142616,0.184088548886884
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29058.Recent feelings or nervousness or anxiety,34211,0.00459735209116243,0.0324594854639677,-0.0590232394182143,0.0682179436005391,0.887372390719827
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29059.Recent inability to stop or control worrying,34224,0.0307858444099898,0.0333208717733236,-0.0345230642657245,0.096094753085704,0.355550403014565
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29060.Recent worrying too much about different things,34214,-0.000428208427112507,0.0312484748817587,-0.0616752191953596,0.0608188023411346,0.989066940092537
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29061.Recent trouble relaxing,34221,0.0282217619692247,0.033066537896033,-0.036588652307,0.0930321762454494,0.393411871513444
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29062.Recent restlessness,34232,0.0530653562487368,0.0481282556545152,-0.041266024834113,0.147396737331587,0.270235796062055
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29063.Recent easy annoyance or irritability,34198,0.0698704569129585,0.0346951984116411,0.00186786802614194,0.137873045799775,0.0440541374712133
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29064.Recent feelings of foreboding,34188,0.0532895097530005,0.0377313060132279,-0.0206638500329262,0.127242869538927,0.157881242053558
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,33042,-0.0095829813853397,0.0255965814751137,-0.0597522810765625,0.0405863183058832,0.708126990377765
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,33042,0.0276680266297398,0.0449113099178761,-0.0603581408092974,0.115694194068777,0.53787175806213
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',33042,0.0042763279668987,0.0562424377517257,-0.105958850026484,0.114511505960281,0.939393954074935
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,33042,0.0697385852808887,0.0616879636318485,-0.0511698234375343,0.190646993999312,0.258294824436034
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29065#2.Symptoms of panic attack_Sweating,33042,-0.036188266322045,0.0418814196998386,-0.118275848933729,0.0458993162896387,0.387576344952861
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,33042,-0.028917661936439,0.0415277859098503,-0.110312122319746,0.0524767984468677,0.486231701548464
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,33042,0.0405452057725863,0.0424871367288836,-0.0427295822160255,0.123819993761198,0.339961862697149
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,33042,0.0184539629217061,0.0381541097676015,-0.0563280922227929,0.0932360180662051,0.628633073773722
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,33042,-0.0531558012320367,0.0517917915057761,-0.154667712583358,0.0483561101192844,0.304761941576561
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29076.Felt loved as a child,34189,0.00557357020588238,0.0308189568976862,-0.0548315853135826,0.0659787257253474,0.856490052512118
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29077.Physically abused by family as a child,34202,0.047695766995618,0.042635132040768,-0.0358690918042872,0.131260625795523,0.263297267945554
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29078.Felt hated by family member as a child,34180,0.0629763172763792,0.0400352273451007,-0.0154927283200182,0.141445362872777,0.115746116418234
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29079.Sexually molested as a child,34072,0.00605412756744253,0.0508620176862961,-0.0936354270976978,0.105743682232583,0.905253737827469
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29080.Someone to take to doctor when needed as a child,34156,-0.0326954589949556,0.0431485105561743,-0.117266539685057,0.051875621695146,0.448623573990048
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,34183,-0.047871577119997,0.0526563201680677,-0.15107796464941,0.0553348104094157,0.363302655852389
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29082.Belittlement by partner or ex-partner as an adult,34103,-0.0125681263196353,0.0398702170252147,-0.0907137516890561,0.0655774990497854,0.752596933707075
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29083.Physical violence by partner or ex-partner as an adult,34184,-0.0193276683598562,0.044658092816386,-0.106857530279973,0.0682021935602603,0.665175427546068
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,34141,-0.0341551074558159,0.0553260550437347,-0.142594175341536,0.0742839604299041,0.537023559463426
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,34146,-0.0190780133331312,0.0551872452008662,-0.127245013926829,0.0890889872605666,0.729578646312267
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29086.Experienced a violent or sexual assault,34179,-0.0261439970024354,0.0517010362083848,-0.12747802797087,0.0751900339659988,0.613095255435098
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29087.Experienced a life-threatening injury or illness,34188,0.086157267272739,0.0372879451435449,0.0130728947913909,0.159241639754087,0.0208761413256598
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29088.Experienced a marital separation or divorce,34197,-0.0727651860014634,0.0327708656490751,-0.136996082673651,-0.00853428932927627,0.0264129770536401
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29089.Experienced the death of a spouse or partner,34206,-0.0105718555557913,0.0413419982959073,-0.0916021722157697,0.070458461104187,0.798174689541856
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,34188,0.0453803769337497,0.0416969943145559,-0.0363457319227798,0.127106485790279,0.276473355038572
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X29091.Frequency of drinking alcohol,34203,-0.213849232112838,0.0275306772844572,-0.267809359590374,-0.159889104635302,8.80015382574274e-15
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,32948,-0.234642730451298,0.0339235684480508,-0.301132924609477,-0.168152536293118,4.95389448085875e-12
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,32966,-0.283841669786114,0.0351256885440019,-0.352688019332358,-0.21499532023987,7.31931914030852e-16
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29104.Ever used cannabis,34196,-0.00467655528270266,0.0422592553000326,-0.0875046956707665,0.0781515851053611,0.911885504838833
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29108.Ever thought that life not worth living,34143,0.0979771070914427,0.0334087913804203,0.0324958759858189,0.163458338197066,0.00336842784938527
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29109.Ever contemplated self-harm,34178,0.0445725724146463,0.0440786657489103,-0.0418216124532179,0.13096675728251,0.311943424451029
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29111.Ever self-harmed,34192,0.020819753655197,0.0683837873925825,-0.113212469634265,0.154851976944659,0.760788136496531
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,34185,0.100733416890207,0.0464569056485517,0.00967788181904623,0.191788951961369,0.0301585307803247
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,33785,0.0899321459265385,0.0558070120537577,-0.0194495976988266,0.199313889551904,0.107107934157642
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,33785,0.000300161862790472,0.0430956690537166,-0.0841673494824941,0.084767673208075,0.994442918055673
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,33785,0.0355667979570017,0.0436037974984361,-0.0498966451399332,0.121030241053937,0.414703308973331
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,33785,0.00202819576915747,0.0559147061434479,-0.107564628272001,0.111621019810315,0.971065431106538
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,34179,0.00680958587967267,0.0306237614930689,-0.0532129866467424,0.0668321584060877,0.824036123807151
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X29153.Pain or discomfort today,34192,0.0591626650609185,0.0292774311020459,0.0017789001009085,0.116546430020929,0.043331920778118
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29154.Anxiety or depression today,34192,0.0548875716321415,0.0352966092985499,-0.0142937825930163,0.124068925857299,0.119969500028041
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29166.Frequency of confiding in someone close,33946,-0.0715437883037369,0.0285075421761704,-0.127418570969031,-0.0156690056384428,0.012101801514101
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,34156,-0.0128648446025173,0.0145073752318361,-0.041299300056916,0.0155696108518815,0.37521954144552
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,34156,-0.00708015105765915,0.0142220047352867,-0.0349552803388211,0.0207949782235028,0.618614632454384
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,34156,-0.05934776687103,0.0207785959695845,-0.100073814971416,-0.0186217187706443,0.00429659301516386
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,34156,0.0642208935266948,0.0182087576181085,0.0285317285952022,0.0999100584581874,0.000422360157491081
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,34156,0.0334017600316529,0.0269967418121691,-0.0195118539201986,0.0863153739835044,0.216023655517327
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,34156,0.0164732021153612,0.014215257201251,-0.0113887019990908,0.0443351062298132,0.246550112968349
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,34157,-0.0241027569278814,0.0157993615552383,-0.0550695055761484,0.00686399172038571,0.12715391286077
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,34157,0.0238455308812423,0.0220478161778198,-0.0193681888272846,0.0670592505897692,0.279485145734207
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,34157,-0.0882775078267257,0.0459968759133673,-0.178431384616926,0.00187636896347415,0.0549874844396706
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,34157,0.0646530508520945,0.0304294096771309,0.00501140788491786,0.124294693819271,0.0336377224315726
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,34157,0.037240949109461,0.0432709462444348,-0.0475701055296312,0.122052003748553,0.389454528836216
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,34157,0.00828778092635079,0.0225607193471592,-0.0359312289940813,0.0525067908467829,0.713362644424271
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29171.Frequency of feeling 'in tune' with people,34046,-0.0639744195951636,0.0357606217540894,-0.134065238233179,0.00611639904285176,0.0736523578747339
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29172.Freuency of feeling that lacks companionship,34131,0.087328606210771,0.0319912855096272,0.0246256866119016,0.15003152580964,0.00634946151581652
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29173.Frequency of feeling left out,34074,0.0747754067664882,0.0331767897388709,0.00974889887830117,0.139801914654675,0.0242282083040898
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29174.Frequency of feeling isolated from others,34105,0.115987754804066,0.0346062191161398,0.0481595653364317,0.1838159442717,0.000806415092468559
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29175.Tendency to bounce back quickly after hard times,34177,-0.105941363776393,0.0291016042634888,-0.162980508132831,-0.0489022194199549,0.00027363212160711
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29176.Ability to make it through stressful events,34177,0.0652858082077911,0.0281500884153699,0.0101116349136662,0.120459981501916,0.0204045775703396
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29177.Quick recovery from stressful events,34177,-0.0504158615345016,0.0286434726191389,-0.106557067868014,0.00572534479901056,0.0784194226184248
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29178.Hard to snap back when something bad happens,34177,0.0654024897678229,0.0282149534135762,0.0101011810772135,0.120703798458432,0.0204695311823955
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29179.Comes through difficult times with little trouble,34177,-0.0993627691773677,0.0285202495886188,-0.155262458371061,-0.0434630799836749,0.000496270564166819
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29180.Tendency to take a long time to get over setbacks,34177,0.0831778390376013,0.0284834755154665,0.0273502270272869,0.139005451047916,0.00350594862380481
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29181.General happiness,34119,0.0609835276758863,0.0297291503973024,0.00271439289717354,0.119252662454599,0.0402642433842184
PLA2G10,Group 10 secretory phospholipase A2,Mental health,X29182.Belief that own life is meaningful,34026,-0.0733039020121967,0.0294468613224937,-0.131019750204284,-0.015588053820109,0.0128141043286174
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,29583,-0.00822837394172503,0.0395233840478965,-0.0856942066756022,0.0692374587921521,0.835088868886752
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X2946.Father's age,30679,0.0223262901378969,0.0128028951937448,-0.00276738444184295,0.0474199647176367,0.0812351219574313
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X2966.Age high blood pressure diagnosed,30297,-0.0125520009961443,0.0102330011429285,-0.0326086832362841,0.00750468124399553,0.220014962657997
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30000.White blood cell (leukocyte) count,51060,0.00192931352310553,0.00431071450642417,-0.00651968690948584,0.0103783139556969,0.654472722386035
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,51060,-0.0590250624403219,0.00504320470647346,-0.0689097436650099,-0.0491403812156339,1.4551446918563e-31
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30020.Haemoglobin concentration,51060,-0.0715714196655364,0.0054747020070553,-0.0823018355993648,-0.060841003731708,6.1840207701402e-39
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30030.Haematocrit percentage,51060,-0.0607918169007344,0.00531644660264898,-0.0712120522419264,-0.0503715815595424,3.30125291425329e-30
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30040.Mean corpuscular volume,51060,0.0106587010184331,0.0042356289048288,0.00235686836496867,0.0189605336718976,0.0118605805513063
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30050.Mean corpuscular haemoglobin,51059,0.000975745113098466,0.00424346670080131,-0.0073414496204721,0.00929293984666903,0.818139725289179
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,51059,-0.0190482773828923,0.00414697367709467,-0.0271763457899978,-0.0109202089757867,4.38298034841271e-06
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,51060,0.0441671362189853,0.00400093311240551,0.0363253073186705,0.0520089651193001,2.84741942271086e-28
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30080.Platelet count,51060,-0.0332929961554696,0.0042469105013385,-0.0416169407380931,-0.0249690515728461,4.6977497369413e-15
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30090.Platelet crit,51060,-0.0201033961298558,0.00435530535272714,-0.028639794621201,-0.0115669976385106,3.9333420579624e-06
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,51060,0.0311049883441133,0.00410513578388875,0.0230589222076913,0.0391510544805352,3.6487767978698e-14
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30110.Platelet distribution width,51060,-0.00582047880382595,0.00411044806710416,-0.0138769570153501,0.00223599940769821,0.156781202502908
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30120.Lymphocyte count,51023,-0.00603744060328609,0.0042844379792653,-0.0144349390426461,0.00236005783607389,0.15880080847481
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30130.Monocyte count,51023,0.0453563175655643,0.00434121245535286,0.0368475411530727,0.0538650939780559,1.67964847609735e-25
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30140.Neutrophill count,51023,-0.00475276938891883,0.00428054477924943,-0.0131426371562477,0.00363709837841006,0.266871717696942
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30150.Eosinophill count,51023,0.0242247802048725,0.00421777289637657,0.0159579453279744,0.0324916150817706,9.37501916935383e-09
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30160.Basophill count,51023,0.0324943376908927,0.0187185533687297,-0.00419402691181744,0.0691827022936029,0.0825855438482666
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30170.Nucleated red blood cell count,51023,0.211996519445049,0.0820548623383884,0.0511689892618081,0.372824049628291,0.00978294705203155
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30180.Lymphocyte percentage,51023,-0.00820600870537433,0.00423474654293406,-0.0165061119295251,9.4094518776431e-05,0.052660605632053
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30190.Monocyte percentage,51023,0.0485904933184377,0.00427734793326024,0.0402068913692476,0.0569740952676278,7.75498328433233e-30
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30200.Neutrophill percentage,51023,-0.011785627907474,0.00419699577010827,-0.0200117396168862,-0.00355951619806182,0.0049869459328957
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30210.Eosinophill percentage,51023,0.02373601145313,0.00416645022894671,0.0155697690043945,0.0319022539018656,1.23265945875467e-08
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30220.Basophill percentage,51023,0.00579773258398672,0.00399020671982335,-0.00202307258686705,0.0136185377548405,0.146238192024576
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30230.Nucleated red blood cell percentage,51023,0.210709800754293,0.0820690059626731,0.0498545490674543,0.371565052441133,0.0102497526576034
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30240.Reticulocyte percentage,50579,-0.0802417459096722,0.00434544898753723,-0.0887588259252452,-0.0717246658940993,1.18257793389459e-75
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30250.Reticulocyte count,50579,-0.0921862441179482,0.00448355841214358,-0.10097401860575,-0.0833984696301468,3.36131954720955e-93
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30260.Mean reticulocyte volume,50579,0.0200187613830554,0.00419424990726082,0.0117980315648242,0.0282394912012866,1.82568054400502e-06
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30270.Mean sphered cell volume,50579,0.0284459618353272,0.00423736907569529,0.0201407184469645,0.03675120522369,1.94407886849549e-11
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30280.Immature reticulocyte fraction,50579,-0.03578727531766,0.00441269930977258,-0.0444361659648142,-0.0271383846705057,5.27934317849001e-16
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30290.High light scatter reticulocyte percentage,50579,-0.0798508740666439,0.00446880863421828,-0.0886097389897117,-0.0710920091435761,5.4943588740653e-71
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30300.High light scatter reticulocyte count,50579,-0.0899584048808173,0.00457776526481401,-0.0989308247998527,-0.0809859849617818,2.33849861120476e-85
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30500.Microalbumin in urine,32131,-0.000658298252317071,0.00837332038676444,-0.0170700062103754,0.0157534097057412,0.93733808614121
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,51116,0.00751177372434284,0.004380373828548,-0.00107375897961123,0.0160973064282969,0.0863805973385643
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30520.Potassium in urine,51063,-0.0269647953841357,0.00407399131734756,-0.0349498183661369,-0.0189797724021345,3.6909252322625e-11
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30530.Sodium in urine,51034,-0.00284628571538973,0.00429749736704705,-0.0112693805548019,0.00557680912402249,0.507776785349183
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30600.Albumin,48309,-0.0539262503971032,0.00450020552529493,-0.0627466532266813,-0.0451058475675252,5.42199224164702e-33
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30610.Alkaline phosphatase,50676,0.0571399034924039,0.00427281917102473,0.0487651779171954,0.0655146290676124,1.18387084571368e-40
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30620.Alanine aminotransferase,50685,-0.0122479498493579,0.00446814880040601,-0.0210055214981537,-0.00349037820056212,0.00612625066733246
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30630.Apolipoprotein A,48095,-0.0162506085599591,0.00493302215231002,-0.0259193319784868,-0.0065818851414315,0.00098829678763047
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30640.Apolipoprotein B,50577,-0.21070244489804,0.00405848081600318,-0.218657067297406,-0.202747822498674,0
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30650.Aspartate aminotransferase,50613,0.0370821115699559,0.00431131538189731,0.0286319334214372,0.0455322897184747,8.32940108556797e-18
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30660.Direct bilirubin,44872,-0.0309596187379671,0.00482865438081377,-0.0404237813243621,-0.0214954561515721,1.47109342631341e-10
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30670.Urea,50672,0.0858933089700163,0.00442393564704423,0.0772223951018096,0.094564222838223,2.19620468983749e-83
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30680.Calcium,48315,-0.0439215248607762,0.00431615344191687,-0.0523811856069333,-0.0354618641146191,2.84237991667066e-24
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30690.Cholesterol,50684,-0.172323154235236,0.00426506115182041,-0.180682674092804,-0.163963634377668,0
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30700.Creatinine,50677,0.077587790121298,0.00484594156620511,0.068089744651536,0.08708583559106,2.00879279723989e-57
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30710.C-reactive protein,50619,-0.0404322387566027,0.00468047440169813,-0.0496059685839311,-0.0312585089292744,6.01515777572767e-18
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30720.Cystatin C,50679,0.0453492325022094,0.00477737315522663,0.0359855811179653,0.0547128838864536,2.44073368591036e-21
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30730.Gamma glutamyltransferase,50680,-0.0574330467042798,0.0043706603495166,-0.0659995409893323,-0.0488665524192272,2.56593567720268e-39
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30740.Glucose,48290,-0.00410706782722397,0.00467467578039043,-0.0132694323567892,0.00505529670234127,0.379638922615456
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),50521,0.0271395607039731,0.0047528403545345,0.0178239936090855,0.0364551277988607,1.14084578672919e-08
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30760.HDL cholesterol,48302,0.0450269441969932,0.00518597175775453,0.0348624395517943,0.0551914488421921,4.11698825927539e-18
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30770.IGF-1,50538,0.0169989467876551,0.00428851154210218,0.00859346416513486,0.0254044294101754,7.39520579064265e-05
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30780.LDL direct,50629,-0.186816855705587,0.0041301968282481,-0.194912041488953,-0.17872166992222,0
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30790.Lipoprotein A,45466,0.0153188249203739,0.00468408481271308,0.00613801868745628,0.0244996311532916,0.00107568857806417
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30810.Phosphate,48268,0.0410664382273381,0.00465783381859312,0.0319370839428956,0.0501957925117806,1.25856927651411e-18
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30830.SHBG,48048,0.0606061506624204,0.00488083278639836,0.0510397184010796,0.0701725829237612,2.71868923435949e-35
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30840.Total bilirubin,50594,-0.124796264179245,0.00423935542045641,-0.13310540080334,-0.116487127555151,2.0795669607285e-187
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30850.Testosterone,46215,-0.0551370531602704,0.00760905489845731,-0.0700508007612468,-0.0402233055592941,4.42788914018261e-13
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30860.Total protein,48306,-0.0612519250514666,0.00439037380271411,-0.0698570577047862,-0.0526467923981469,4.59641542520384e-44
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30870.Triglycerides,50675,-0.127900605478677,0.00469050609153592,-0.137093997418087,-0.118707213539267,1.82071743532065e-161
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30880.Urate,50649,-0.0704216342802724,0.00521471870660948,-0.080642482945227,-0.0602007856153178,2.02744676386121e-41
PLA2G10,Group 10 secretory phospholipase A2,Blood and urine assays,X30890.Vitamin D,49163,0.0258906189834699,0.00465249966316577,0.016771719643665,0.0350095183232748,2.65046701956057e-08
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X3137.Number of measurements made,49561,0.0276284540400941,0.0209728627451684,-0.013478356940436,0.0687352650206243,0.187735697198167
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X3143.Ankle spacing width,40066,-0.00323691321812193,0.00725200705249356,-0.0174508470410093,0.0109770206047654,0.65535263864876
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",40065,-0.0252471876211377,0.00587628094439182,-0.0367646982721457,-0.0137296769701297,1.74599680932902e-05
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X3146.Speed of sound through heel,40066,-0.0305519285251396,0.00567027282595574,-0.0416656632640128,-0.0194381937862663,7.22436660211532e-08
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",40066,-0.0296039697328394,0.0057392185957551,-0.0408528381805194,-0.0183551012851594,2.52401764001589e-07
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X3148.Heel bone mineral density (BMD),40064,-0.030109022262091,0.00572407547632916,-0.0413282101956961,-0.0188898343284858,1.45904045908217e-07
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X3526.Mother's age at death,40789,0.00949555907084713,0.00546900073702632,-0.00122368237372446,0.0202148005154187,0.0825382803434215
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X3581.Age at menopause (last menstrual period),40189,-0.00464753044238581,0.00538821176106886,-0.0152084254940808,0.00591336460930915,0.388405385020269
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",30127,-0.00484770686144936,0.00921368373130757,-0.0229065269748122,0.0132111132519135,0.598810042920294
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4100.Ankle spacing width (left),33297,-0.0168999751070087,0.0097331304733475,-0.0359769108347698,0.00217696062075242,0.082539437067349
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4101.Heel broadband ultrasound attenuation (left),33295,-0.0153690451416418,0.00798155345901133,-0.031012889921304,0.000274799638020445,0.05419003363289
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4103.Speed of sound through heel (left),33297,-0.0283094844171801,0.00777732516842792,-0.0435530417472988,-0.0130659270870614,0.000274190400592749
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",33297,-0.0244650027383312,0.00784252106980386,-0.0398363440351467,-0.00909366144151559,0.00181720325789888
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4105.Heel bone mineral density (BMD) (left),33295,-0.0241866686147852,0.00782376681244665,-0.0395212515671806,-0.00885208566238975,0.00199810971377946
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",33297,-0.0244533881646707,0.0078420777619495,-0.0398238605780917,-0.00908291575124968,0.00182525858982612
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4119.Ankle spacing width (right),33301,-0.0235982604363446,0.00959353814003517,-0.0424015951908135,-0.00479492568187566,0.0139201239244102
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4120.Heel broadband ultrasound attenuation (right),33301,-0.0112555772214508,0.00798521026190274,-0.0269065893347802,0.00439543489187852,0.158706850453594
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4122.Speed of sound through heel (right),33301,-0.0219159178820012,0.00780187658663702,-0.0372075959918097,-0.00662423977219262,0.00497957679223572
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",33301,-0.0187387525807231,0.00785763637999184,-0.0341397198855071,-0.00333778527593908,0.0171101603547018
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4124.Heel bone mineral density (BMD) (right),33299,-0.018434325746278,0.00783714954231085,-0.0337951388492073,-0.00307351264334874,0.0186859222191377
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",33301,-0.0187308502714444,0.00785767667295784,-0.0341318965504418,-0.00332980399244703,0.0171575260391052
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4194.Pulse rate,33566,0.0426046806924771,0.00760500934232103,0.0276988623815279,0.0575104990034263,2.17817318418695e-08
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4195.Pulse wave reflection index,33566,-0.029811394963006,0.00764685933376702,-0.0447992392571894,-0.0148235506688227,9.74784052651821e-05
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4196.Pulse wave peak to peak time,33563,0.0132519924906472,0.00696474738983468,-0.00039891239342882,0.0269028973747231,0.0571080535924985
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4198.Position of the pulse wave peak,33566,-0.0216433453494921,0.00674764849843771,-0.03486873640643,-0.00841795429255421,0.00134338664101557
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4199.Position of pulse wave notch,33566,0.028225130782853,0.00750771931106686,0.013510000933162,0.0429402606325441,0.0001713302736672
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4200.Position of the shoulder on the pulse waveform,33566,-0.00634034560651256,0.00674299859121011,-0.0195566228452844,0.00687593163225926,0.347095917746294
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4269.Number of triplets attempted (left),33466,-0.0813038429631884,0.0927400168600213,-0.26307427600883,0.100466590082453,0.380680796472174
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4270.Volume level set by participant (left),33380,-0.0215217219927407,0.0290128200524818,-0.078386849295605,0.0353434053101236,0.458227787738445
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4276.Number of triplets attempted (right),33470,-0.123524167145464,0.0891774107623091,-0.29831189223959,0.0512635579486623,0.166040654194548
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X4277.Volume level set by participant (right),33369,-0.0197972011835094,0.028722961980492,-0.0760942066652737,0.0364998042982549,0.490686095406325
PLA2G10,Group 10 secretory phospholipase A2,Cognitive function,X4288.Time to answer,33638,-0.00318140346520962,0.00849755376787035,-0.0198366088502355,0.0134738019198163,0.708122446216619
PLA2G10,Group 10 secretory phospholipase A2,Cognitive function,X4290.Duration screen displayed,33638,0.000421456568229509,0.00758687166532635,-0.0144488118958101,0.0152917250322692,0.95570089129847
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X46.Hand grip strength (left),51876,-0.044433065119854,0.00620032242755653,-0.0565856970778648,-0.0322804331618432,7.90260824602723e-13
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X47.Hand grip strength (right),51880,-0.049139758926289,0.00616869714606504,-0.0612304053325764,-0.0370491125200015,1.70224083501996e-15
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X48.Waist circumference,51965,-0.120855989129893,0.00822401872251055,-0.136975065826014,-0.104736912433773,1.05435324100559e-48
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X4803.Tinnitus,33477,0.0568693629746668,0.0349506884119274,-0.011633986312711,0.125372712262044,0.103744111967049
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X4825.Noisy workplace,33611,-0.0213004319441913,0.0499766286958206,-0.119254624188,0.0766537602996171,0.669966409055344
PLA2G10,Group 10 secretory phospholipase A2,Working and living environment,X4836.Loud music exposure frequency,33555,-0.0947660906610215,0.0575551457226873,-0.207574176277489,0.0180419949554456,0.0996898711120867
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X49.Hip circumference,51962,0.0262842424333569,0.00699380054055572,0.0125763933738676,0.0399920914928461,0.000171479695819666
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X50.Standing height,51960,-0.0146881236890082,0.0057228618234361,-0.025904932862943,-0.00347131451507346,0.0102762404023208
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X5057.Number of older siblings,32543,0.0557189819688666,0.0309788030170157,-0.00499947194448409,0.116437435882217,0.0721166483979233
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,X51.Seated height,51834,-0.0122485257621704,0.00574474867581794,-0.0235082331667736,-0.000988818357567239,0.033005395074471
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X5181.Ever had eye surgery,30634,-0.123394912365919,0.0686552529029279,-0.257959208055658,0.0111693833238193,0.0723348985948648
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X5186.Duration visual-acuity screen displayed (right),30616,-0.0217262561378687,0.00883549787942655,-0.0390438319815447,-0.00440868029419263,0.0139607700933338
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X5188.Duration visual-acuity screen displayed (left),30618,-0.0212759889619518,0.00874296900767741,-0.0384122082169995,-0.00413976970690403,0.0149819785869027
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X5190.Duration at which refractometer first shown (right),30542,-0.0197243250123787,0.00883102493565434,-0.0370331338862612,-0.00241551613849622,0.0255504427372788
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X5193.Duration at which refractometer first shown (left),30543,-0.0160938289154928,0.00887377850292867,-0.033486434781233,0.0012987769502474,0.069782544131678
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,"X5199.logMAR, initial (right)",30597,-0.0149014183582252,0.0363235362855192,-0.0860955494778428,0.0562927127613923,0.681643178829248
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X5200.Final number of letters displayed (right),30597,-0.436103600302048,0.265848372929929,-0.957166411244709,0.0849592106406128,0.100968588795537
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,"X5201.logMAR, final (right)",30549,0.000906833350034371,0.00920168258743742,-0.017128464521343,0.0189421312214117,0.921498160727272
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X5202.Number of rounds to result (right),30597,-0.0172809239222251,0.0337801802285261,-0.0834900771701363,0.0489282293256861,0.608970460083821
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,"X5206.logMAR, initial (left)",30596,0.0380907137220615,0.0360551026356604,-0.0325772874438328,0.108758714887956,0.29080041067865
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X5207.Final number of letters displayed (left),30596,-0.388189736041906,0.222638640859531,-0.824561472126586,0.0481820000427737,0.0812812463666932
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,"X5208.logMAR, final (left)",30534,0.00253150109426712,0.00914024924884944,-0.0153833874334778,0.020446389622012,0.781818748751678
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X5209.Number of rounds to result (left),30594,0.000940921131676275,0.0337734224597539,-0.0652549868894413,0.0671368291527938,0.977774869738537
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",30298,-0.0331554814617936,0.00907063519632559,-0.0509339264465917,-0.0153770364769954,0.000259181569382491
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",30298,-0.0352167311533101,0.00914186070655314,-0.0531347781381543,-0.017298684168466,0.000118289685604661
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X5256.Corneal hysteresis (right),30298,0.0107201079391729,0.00908248924748504,-0.00708157098589774,0.0285217868642436,0.237926932595649
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X5257.Corneal resistance factor (right),30298,-0.00887122642511259,0.00909346070887518,-0.0266944094145079,0.00895195656428277,0.329322380924038
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",30294,-0.0395512431790791,0.00902569970793278,-0.0572416146066274,-0.0218608717515309,1.19615429330264e-05
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",30294,-0.0327492203324847,0.00899790017586606,-0.0503851046771821,-0.0151133359877872,0.00027536659008248
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X5264.Corneal hysteresis (left),30294,0.0198051762118856,0.00924242649606305,0.00169002027960198,0.0379203321441691,0.0321659681279907
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X5265.Corneal resistance factor (left),30294,-0.000974763599590508,0.00914128019976517,-0.0188916727911302,0.0169421455919492,0.915083671571291
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,29893,0.080840505167338,0.160014262247198,-0.232787448837169,0.394468459171845,0.613433131599586
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",51873,0.0171470660662329,0.0243756463001471,-0.0306292006820554,0.0649233328145212,0.481780877003942
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",51873,0.0171951177625338,0.0249348903238574,-0.0316772672722267,0.0660675027972942,0.490451164091562
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",51873,0.0262986575195202,0.0631828119862819,-0.0975396539735922,0.150136969012633,0.677244090406204
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",51873,0.0120526338478911,0.0105062362230715,-0.00853958914932893,0.0326448568451112,0.251313713935029
PLA2G10,Group 10 secretory phospholipase A2,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",51873,-0.0246008067152362,0.00960521568728956,-0.0434270294623237,-0.00577458396814862,0.0104366539702858
PLA2G10,Group 10 secretory phospholipase A2,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",37147,-0.000767210600296591,0.011880989929234,-0.0240539508615953,0.0225195296610021,0.948513696801595
PLA2G10,Group 10 secretory phospholipase A2,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",37147,0.0136677501662107,0.0296551497821242,-0.0444563434067527,0.0717918437391741,0.644885707764986
PLA2G10,Group 10 secretory phospholipase A2,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",37147,0.0399114513005351,0.0232060530969157,-0.00557241276941975,0.0853953153704899,0.0854800027121711
PLA2G10,Group 10 secretory phospholipase A2,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",37147,-0.0191015518344403,0.0142781541599649,-0.0470867339879715,0.00888363031909101,0.180980189148396
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,51958,-0.0313252811798902,0.0197502904284268,-0.0700358504196067,0.00738528805982641,0.112735638037286
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,51958,-0.0313252811798902,0.0197502904284268,-0.0700358504196067,0.00738528805982641,0.112735638037286
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),51958,-0.00751903296390912,0.0157992043646802,-0.0384854735186823,0.0234474075908641,0.634140761492725
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',51958,0.0319567503363602,0.024643081654529,-0.0163436897065167,0.0802571903792371,0.194716446652042
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),51958,0.0128151474488824,0.0604655062402561,-0.10569724478202,0.131327539679784,0.832154278074501
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),51958,-0.0425607081554206,0.0424296409631084,-0.125722804443113,0.0406013881322718,0.315826722558895
PLA2G10,Group 10 secretory phospholipase A2,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,51958,-0.073499874335946,0.0680375694370302,-0.206853510432525,0.0598537617606333,0.280025356841828
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,51873,0.0291085306118637,0.0127137941629547,0.0041894940524726,0.0540275671712549,0.022056515250093
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,51873,0.0375548864930814,0.0212340361707929,-0.00406382440167264,0.0791735973878355,0.0769688555375968
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,51873,-0.00594837609287441,0.0112501600571509,-0.0279986898048902,0.0161019376191413,0.596992172593356
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,51873,0.0424675939884155,0.0208851699616728,0.00153266086353678,0.0834025271132943,0.042023238361138
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,51873,0.0392584566438461,0.0203532844420797,-0.000633980862630154,0.0791508941503223,0.0537596489560482
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,51873,-0.00825095290849794,0.0114142639221321,-0.0306229101958769,0.014121004378881,0.469770015392056
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,31775,0.171512986420992,0.0430271469086726,0.0871797784799935,0.25584619436199,6.78043104851886e-05
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,31775,0.135193834974675,0.0281867346275776,0.0799478351046229,0.190439834844727,1.64765263092468e-06
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,31775,0.137311940637379,0.0362531665512703,0.0662557341968893,0.208368147077869,0.000153336601849142
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,31775,-0.137957706421427,0.0321928891059243,-0.201055769069039,-0.0748596437738156,1.84790170347638e-05
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,51868,0.0414237569002984,0.0311832859913849,-0.019695483642816,0.102542997443413,0.184058329672993
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6151#2.Fractured bone site(s)_Leg,51868,0.00741878060878597,0.0528399474703721,-0.0961475164331434,0.110985077650715,0.888344212026446
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6151#3.Fractured bone site(s)_Hip,51868,0.143719554821188,0.085410507847527,-0.0236850405599647,0.311124150202341,0.0924461711836295
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6151#4.Fractured bone site(s)_Spine,51868,0.0899063733273563,0.0820794263801219,-0.0709693023776826,0.250782049032395,0.273369358296
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,51868,0.0231022549541972,0.0258702178065898,-0.0276033719467188,0.0738078818551132,0.371861896516596
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6151#6.Fractured bone site(s)_Arm,51868,0.0831569135865493,0.0369226402872314,0.0107885386235757,0.155525288549523,0.0243179533287439
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,51868,0.0180654607707559,0.0183167078438075,-0.0178352866031068,0.0539662081446186,0.324002877558292
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",33867,0.0487957539983748,0.02775284266301,-0.00559981762112477,0.103191325617874,0.0787416463180255
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",33867,-0.00193149162885526,0.0323263042490823,-0.0652910479570565,0.061428064699346,0.952356141150015
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",33867,0.0831903651987205,0.0415223823294402,0.00180649583301762,0.164574234564423,0.0451515484196741
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",33867,-0.00412931006664608,0.0144559542754924,-0.0324629804466112,0.0242043603133191,0.775154250740114
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",37429,0.078510042099502,0.0144953402704643,0.0500991751693921,0.106920909029612,6.1955072495848e-08
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",37429,-0.0513119090497599,0.0126555334939452,-0.0761167546978925,-0.0265070634016272,5.05341786789851e-05
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",37429,-0.0035013604616414,0.0118759573445625,-0.0267782368569838,0.019775515933701,0.768130267947574
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",37429,-0.0449623631178942,0.0285439017058803,-0.10090841046142,0.0109836842256313,0.115234589915272
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",37429,-0.0062490353841875,0.0170696492487039,-0.0397055479116471,0.0272074771432721,0.714303559474102
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",37429,0.0361378520103131,0.0198514242422882,-0.00277093950457179,0.0750466435251981,0.0687186867441858
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,51873,0.0358908006106387,0.0278011122558438,-0.0185993794108151,0.0903809806320926,0.196719990685468
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,51873,-0.0223442915596048,0.0179083924507146,-0.0574447407630055,0.0127561576437959,0.212151794597157
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,51873,-0.0183291257450182,0.0700843197120403,-0.155694392380617,0.119036140890581,0.793686072234792
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,51873,0.0727885854167751,0.0176037574972061,0.0382852207222512,0.107291950111299,3.56270219606086e-05
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,51873,-0.0034616137465672,0.0211911000828393,-0.0449961699089322,0.0380729424157978,0.870242305508588
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),51873,0.0666639142592118,0.0237399272852981,0.0201336567800275,0.113194171738396,0.00498711038435645
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,51873,-0.00834345607206008,0.00839337304378014,-0.0247944672378692,0.00810755509374899,0.320205928683272
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,28768,0.0757879052251311,0.0281225285634006,0.0206677492408659,0.130908061209396,0.00706786794114819
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,28768,0.0333504101784805,0.036679699638859,-0.0385418011136832,0.105242621470644,0.363277663822712
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,28768,-0.0104933860382038,0.0245379154330495,-0.0585877002869808,0.0376009282105731,0.66893480997672
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,28768,-0.0344605178820483,0.0222126284646104,-0.0779972696726846,0.00907623390858805,0.120880817121072
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,51998,0.0052929406213246,0.00956147692085026,-0.0134475541435419,0.0240334353861911,0.579878095872425
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,51998,0.0255742403081467,0.0257035335271261,-0.0248046854050205,0.0759531660213139,0.319759679385948
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,51998,-0.0049009243652645,0.00933627278484218,-0.0232000190235552,0.0133981702930262,0.599633494863082
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,51998,0.00133323587465537,0.00931510863855178,-0.0169243770569061,0.0195908488062169,0.886191579508495
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,51998,0.0159958581946774,0.0134528424746906,-0.0103717130557161,0.042363429445071,0.234437383008785
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,51998,0.0108720115192485,0.0119210132060185,-0.0124931743645477,0.0342371974030447,0.361774602322071
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,51998,-0.0177069925950918,0.00999331870621658,-0.0372938972592763,0.0018799120690927,0.0764250157996461
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,51998,0.0707763398680963,0.0272617838674877,0.0173432434878204,0.124209436248372,0.00943183032382508
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,43392,-0.0233345720635377,0.00991033697679448,-0.0427588325380549,-0.00391031158902053,0.0185543504823786
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,43392,-0.0761705563999635,0.0109593407252065,-0.0976508642213681,-0.0546902485785588,3.76403886672253e-12
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,43392,0.0677737363603406,0.0110045474011677,0.0462048234540519,0.0893426492666294,7.48214136791973e-10
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,43392,0.0427311831884229,0.0140551822536184,0.0151830259713308,0.0702793404055149,0.00236709340795691
PLA2G10,Group 10 secretory phospholipase A2,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,43392,0.0260278039266124,0.00997729469942991,0.00647230631572978,0.045583301537495,0.0090957333585482
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,51750,-0.0287532754410593,0.0101136411207518,-0.0485760120377328,-0.0089305388443858,0.00447215492286434
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,51750,-0.00173753141363375,0.00812984851493816,-0.0176720345029125,0.014196971675645,0.830765073426876
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,51750,0.0191063306357149,0.00889521425788748,0.00167171069025548,0.0365409505811744,0.0317277952052984
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,51750,0.0108550861980763,0.01953282930685,-0.0274292592433496,0.0491394316395022,0.578396255103157
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),51762,-0.0108194754338971,0.00918552486445313,-0.0288231041682253,0.00718415330043102,0.238853436836934
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,51762,-0.0102346963593568,0.0164815347225749,-0.0425385044156036,0.0220691116968899,0.534618247313884
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),51873,0.016894953606825,0.00877489184390922,-0.000303834407237108,0.034093741620887,0.0541928444075265
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,51873,0.0239180095766883,0.00994796962804556,0.00441998910571897,0.0434160300476576,0.0162095857462345
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,51873,0.0673940459134955,0.012999980536362,0.0419140840622261,0.0928740077647649,2.18522766462821e-07
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,51873,0.0299879990590127,0.018738720137142,-0.00673989240978563,0.066715890527811,0.109538535412681
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,51873,0.0744565718158211,0.0194099012299535,0.0364131654051123,0.11249997822653,0.000125329311382426
PLA2G10,Group 10 secretory phospholipase A2,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,51873,0.00896819195156336,0.0251742994461447,-0.0403734349628803,0.058309818866007,0.721660619144602
PLA2G10,Group 10 secretory phospholipase A2,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",40066,-0.0296032181066011,0.00573920862212467,-0.0408520670059655,-0.0183543692072367,2.52565958520477e-07
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X864.Number of days or week walked 10+ minutes,51360,-0.0160304806031462,0.0169620865619971,-0.0492761702646605,0.0172152090583681,0.3446279725406
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X874.Duration of walks,47301,-0.00754646576836027,0.00450568950107655,-0.0163776171904703,0.00128468565374977,0.0939724848729673
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,50289,-0.0244192281765248,0.016557334692186,-0.0568716041732093,0.00803314782015973,0.140270859264763
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X894.Duration of moderate activity,44170,-0.0180018066718668,0.0201283958719693,-0.0574534625809265,0.021449849237193,0.371146214794298
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X90087.No-wear time bias adjusted average acceleration,30409,0.0123220031602309,0.00922794251377683,-0.00576476416677171,0.0304087704872334,0.181831627492564
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,50281,-0.0298091373439957,0.0170199624179309,-0.0631682636831402,0.00354998899514886,0.0798851100429926
PLA2G10,Group 10 secretory phospholipase A2,Physical activities,X914.Duration of vigorous activity,38058,-0.00288709425977639,0.0059556755665076,-0.0145602183701313,0.0087860298505785,0.627851905538862
